The Hematologist

VERONA and the Future of High-Risk Myelodysplastic Syndromes: A Conversation With Dr. Jacqueline Garcia

The Hematologist — Mon, 09 Mar 2026 18:15:33 -0400

In this episode, Contributing Editor Charlotte Brierley, MD, PhD, speaks with Jacqueline Garcia, MD, assistant professor at the Dana Farber Cancer Institute and Harvard Medical School and an expert in myeloid neoplasms. Their discussion focuses on the VERONA trial and its impact on the myelodysplastic syndromes community.

Leading With Lived Experience: Dr. Brian Koffman, Patient and CEO of the CLL Society

The Hematologist — Thu, 05 Feb 2026 13:51:37 -0500

In this episode Contributing Editor Brian Hill, MD, talks with Brian Koffman, MDCM, retired family doctor and chronic lymphocytic leukemia patient. Dr. Koffman is co-founder and chief medical officer of the CLL Society. They discuss Dr. Koffman’s journey as both a physician and a patient.

An Homage to the Treg Graft in Allogeneic Transplantation

The Hematologist — Wed, 22 Oct 2025 11:31:27 -0400

In this episode, Shaji Kumar, MD, editor-in-chief of The Hematologist, and consultant in hematology at Mayo Clinic in Rochester, Minnesota, talks with Robert Negrin, MD, professor of medicine at Stanford University and president-elect of ASH. They discuss recent developments in reducing graft versus host disease in allogenic stem cell transplant.

Less Is More: Low-Dose Direct Oral Anticoagulants for Extended Venous Thromboembolism Prophylaxis in Higher-Risk Patients

The Hematologist — Thu, 11 Sep 2025 16:26:06 -0400

In this episode, Contributing Editor Samuel Wilson, MD, talks with Francis Couturaud, MD, PhD, Professor of Pulmonology at University of Brest in France. They discuss low-dose direct oral anticoagulants for extended venous thromboembolism prophylaxis.

GATA Lot to Learn: Decoding the Drivers of Down Syndrome-Associated Acute Leukemias

The Hematologist — Sun, 17 Aug 2025 14:54:31 -0400

In this episode, Contributing Editor, Lauren Pommert, MD, MS, leads a conversation with Karen Rabin, MD, PhD, pediatric oncologist at the University of California, San Francisco, and Hans Hitzler, MD, with SickKids Children's Hospital in Toronto. They discuss advances in understanding the disease biology of down syndrome associated acute leukemia. Support for this episode provided by Autolus.

More Than Medicine: Peer Connection as a Therapeutic Adjunct in Acute Leukemia

The Hematologist — Mon, 28 Jul 2025 10:40:42 -0400

In this episode, Contributing Editor Lori Muffly, MD, MS, leads a conversation with two patients — Matt and Rohan — both of whom have undergone cord blood transplants for their acute myeloid leukemia. They discuss the value of peer connection as a vital component of their leukemia and transplant journey.

Pomalidomide: A Step on the PATH Forward for Treatment of Hereditary Hemorrhagic Telangiectasia

The Hematologist — Mon, 23 Jun 2025 14:47:51 -0400

In this episode, Contributing Editor Surbhi Shah, MBBS, MD, a clinician, researcher, and educator at Mayo Clinic in Phoenix, Arizona, talks with Keith McCrae, MD, director of classical hematology at the Taussig Cancer Institute and professor of molecular medicine at the Cleveland Clinic Lerner College of Medicine in Ohio. They discuss a recent paper co-authored by Dr. McCrae, “Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia.” Support for this episode provided by Autolus.

Dual BCR::ABL1 Inhibition Shows Promise in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

The Hematologist — Sat, 24 May 2025 14:46:28 -0400

In this episode, Contributing Editor Scott Furlan, MD, PhD, an assistant professor at the Fred Hutch Cancer Center and Department of Pediatrics at the University of Washington in Seattle, talks with Daniel J. DeAngelo, MD, PhD, chief of the leukemia division at the Dana-Farber Cancer Institute and a professor of medicine at Harvard Medical School in Boston. They discuss a phase I study with recent results that point to a potentially significant advance in the treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.

When to STOP Treatment for Immune Thrombocytopenia in Patients Experiencing a Complete Response on Thrombopoietin Receptor Agonists

The Hematologist — Fri, 16 May 2025 14:29:34 -0400

In this episode, Contributing Editor Michael Scott, MD, a hematologist at St. Michael’s Hospital in Toronto, Canada, and an assistant professor at the University of Toronto, talks with Marc Michel, MD, MSc, head of the internal medicine and clinical immunology department at Henri Mondor University Hospital in Créteil, France. They talk about long-term follow-up of the STOPAGO study, which focuses on the use of thrombopoietin receptor agonists on patients with immune thrombocytopenia. Support for this episode provided by Autolus.

No Scientific Link Found Between Sickle Cell Trait and Sudden Death

The Hematologist — Mon, 28 Apr 2025 14:26:35 -0400

In this episode, Contributing Editor Samuel Wilson, MD, MSCR, an assistant professor of hematology at the University of North Carolina at Chapel Hill, talks with Michael DeBaun, MD, MPH, a professor of pediatrics and medicine at Vanderbilt University Medical Center and founder and director of the Vanderbilt-Meharry Sickle Cell Disease Center of Excellence. They talk about a systematic literature review, led by Dr. DeBaun and published in the journal Blood, that found no link between sickle cell trait and sudden death – a finding that challenges a long-standing myth about the trait. Support for this episode provide by Siemens Healthineers.

Does This Star ‘GLO’? Taking Aim at Second-Line Diffuse Large B-Cell Lymphoma With Glofitamab Plus Gemcitabine and Oxaliplatin

The Hematologist — Mon, 31 Mar 2025 11:23:00 -0400

In this episode, Contributing Editor Tycel Phillips, MD, an associate professor of medicine and a hematologist-oncologist at City of Hope Medical Center in Duarte, California, talks with Jeremy Abramson, MD, director of the Jon and Jo Ann Hagler Center for Lymphoma at Massachusetts General Hospital and an associate professor of medicine at Harvard Medical School. They talk about the use of Glofit-GemOx in the treatment of patients with relapsed or refractory diffuse large B-cell lymphoma. Support for this episode provided by Autolus.

The Rise of the HLA-Mismatched Unrelated Donor Transplant in the U.S.

The Hematologist — Thu, 27 Feb 2025 10:28:23 -0500

In this episode, Contributing Editor Lori Muffly, MD, MS, an associate professor of medicine at Stanford University where she focuses on cellular therapy for adults with acute leukemia, talks with Steven Devine, MD, the chief medical officer at the National Marrow Donor Program. They talk about the rise of HLA-mismatched unrelated donor transplants in the U.S.

The End of Transplant for Mantle Cell Lymphoma

The Hematologist — Fri, 31 Jan 2025 15:31:32 -0500

In this episode, Contributing Editor Brian Hill, MD, PhD, director of the lymphoid malignancies program at the Cleveland Clinic Taussig Cancer Institute in Cleveland, Ohio, talks with Tim Fenske, MD, who at the time of this recording was joining the transplant and cell therapy group at Sarah Cannon Methodist Healthcare in San Antonio, Texas. Dr. Fenske previously led the lymphoma program at the Medical College of Wisconsin. They talk about a new study that found a lack of benefit in autologous stem cell transplantation for patients with mantle cell lymphoma.

DREAMMing of a Better Tomorrow: Belantamab-Based Triplet Therapy for Relapsed/Refractory Multiple Myeloma

The Hematologist — Sat, 21 Dec 2024 11:00:00 -0500

In this episode, Contributing Editor Ajai Chari, MD, a professor of clinical medicine and director of the myeloma program at the University of California San Francisco, talks with Meletios Dimopoulos, MD, a professor and chair of the Department of Clinical Therapeutics at the National and Kopodistrian University of Athens School of Medicine in Athens, Greece. They talk about a recent paper co-authored by Dr. Dimopoulos: “Belantamab Mafodotin, Pomalidomide (PA), and Dexamethasone in Multiple Myeloma.”

Haploidentical Stem Cell Transplantation Is an Acceptable Transformative Therapy for Young Adults With Sickle Cell Disease

The Hematologist — Wed, 27 Nov 2024 14:43:27 -0500

In this episode, Contributing Editor Samuel Wilson, MD, an assistant professor of hematology at the University of North Carolina Chapel Hill, talks with Adetola Kassim, MD, a professor of medicine in the division of hematology and oncology at Vanderbilt University Medical Center. They talk about a recent paper co-authored by Dr. Kassim: “An International Learning Collaborative Phase 2 Trial for Haploidentical Bone Marrow Transplant in Sickle Cell Disease.”

Enhancing Risk Stratification for Pediatric B-Cell Acute Lymphoblastic Leukemia: No Longer a ‘PI’ in the Sky Idea?

The Hematologist — Fri, 11 Oct 2024 12:03:48 -0400

In this episode, Contributing Editor Lauren Pommert, MD, a pediatric oncologist specializing in children with leukemia at Cincinnati Children's in Cincinnati, Ohio, talks with Natalie DelRocco, PhD, a senior statistician for the Children’s Oncology Group’s Bone Tumors Committee and an assistant professor of clinical population and public health sciences in the Division of Biostatistics at the University of Southern California in Los Angeles. They talk about a recent paper co-authored by Dr. DelRocco: “Enhanced Risk Stratification for Children and Young Adults With B-Cell Acute Lymphoblastic Leukemia: A Children’s Oncology Group Report.”

A Leap of Faith? Elimination of Autologous Stem Cell Transplantation for Patients With Mantle Cell Lymphoma in First Remission

The Hematologist — Mon, 16 Sep 2024 10:45:28 -0400

In this episode, Contributing Editor Tycel Phillips, MD, an associate professor of medicine and a hematologist-oncologist at City of Hope Medical Center in Duarte, California, talks with Martin Dreyling, MD, a professor of medicine and head of the lymphoma program at LMU Hospital in Munich. They discuss the TRIANGLE trial, conducted by Dr. Dreyling and colleagues, for the European Mantle Cell Lymphoma Network.

Anticoagulation Stewardship

The Hematologist — Thu, 29 Aug 2024 14:48:22 -0400

In this episode, Contributing Editor Surbhi Shah, MD, a classical hematologist at Mayo Clinic in Phoenix, leads a conversation about anticoagulation stewardship. Her guests are Allison Burnett, PharmD, PhC, an antithrombosis stewardship pharmacist at the University of New Mexico Hospital and president of the Anticoagulation Forum, and Geoffrey Barnes, MD, MSc, an associate professor and vascular medicine specialist at the University of Michigan and president-elect of the Anticoagulation Forum.

Blood Global Hematology Editor-in-Chief Shares Vision

The Hematologist — Wed, 17 Jul 2024 15:01:16 -0400

In this episode, Editor-in-Chief Shaji Kumar, MD, a professor of medicine at Mayo Clinic in Rochester, Minnesota, talks with Jorge Cortes, MD, the inaugural editor-in-chief of Blood Global Hematology, one of the latest additions to the growing Blood journals portfolio. Dr. Cortes, director of the Georgia Cancer Center at Augusta University, shares his vision for the journal and his thoughts on how it will impact the hematologic research community around the world. Support for this episode provided by Rigel Pharmaceuticals.

One on One With Dr. Fred Appelbaum

The Hematologist — Wed, 26 Jun 2024 15:57:53 -0400

In this episode, Contributing Editor Lori Muffly, MD, MS, an associate professor of medicine specializing in blood and marrow transplantation and cellular therapy at Stanford University in California, talks with Fred Appelbaum, MD, executive vice president and deputy director at the Fred Hutchinson Cancer Center in Seattle, and a professor of medicine in the division of hematology and oncology at the University of Washington. They talk about Dr. Appelbaum’s book, Living Medicine: Don Thomas, Marrow Transplantation, and the Cell Therapy Revolution.

Genetic Switch System Suggests Targeting of Mutant JAK2 Reverses Myeloproliferative Neoplasms

The Hematologist — Fri, 21 Jun 2024 12:14:52 -0400

In this episode, Contributing Editor Bethan Psaila, MD, PhD, an associate professor of hematology at the University of Oxford’s MRC Weatherall Institute of Molecular Medicine, talks with Andrew Dunbar, MD, an assistant professor and independent lab investigator at MD Anderson Cancer Center in Houston, Texas. They discuss Dr. Dunbar’s paper recently published in Cancer Discovery: “JAK2V617F reversible activation shows its essential requirement in myeloproliferative neoplasms.”

Venous Thromboembolism Risk Markers and Discontinuing Combined Hormonal Contraceptives

The Hematologist — Tue, 07 May 2024 10:09:52 -0400

In this episode, Contributing Editor Samuel Wilson, MD, an assistant professor of hematology at the University of North Carolina, Chapel Hill, talks with Marc Blondon, MD, an attending physician in the division of angiology and hemostasis with the University Hospitals of Geneva (Switzerland). They talk about a paper co-authored by Dr. Blondon titled, “Longitudinal profile of estrogen-related thrombotic biomarkers after cessation of combined hormonal contraceptives.” Dr. Wilson wrote about the study in a recent issue of The Hematologist.

Growing the Next Generation of Hematologists

The Hematologist — Mon, 15 Apr 2024 15:49:43 -0400

In this episode, Editor-in-Chief Shaji Kumar, MD, a professor of medicine at Mayo Clinic in Rochester, Minnesota, talks with Leslie Ellis, MD, a professor of internal medicine at Atrium Health Wake Forest Baptist in Winston Salem, North Carolina. They discuss the ASH Ambassador Program, which is designed to support the recruitment and retention of trainees into hematology. Dr. Ellis is chair of an ASH oversight subcommittee for that program.

Women in Hematology

The Hematologist — Tue, 26 Mar 2024 10:22:22 -0400

In this episode, Tamara Dunn, MD, a clinical associate professor of medicine in the division of hematology at Stanford University in Stanford, California, and co-chair of ASH’s Women in Hematology Working Group, hosts a conversation with Toyosi Onwuemene, MD, an associate professor of medicine, specializing in hemostasis/thrombosis, at Duke University in Durham, North Carolina, and Nina Shah, MD, the global clinical head for multiple myeloma research and development at AstraZeneca. They talk about career choices and opportunities for women in hematology, both in academic medicine and industry. Support for this episode provided by Sanofi.

Four Is Better Than Three: Will We Finally Agree?

The Hematologist — Mon, 18 Mar 2024 09:48:42 -0400

In this episode, Contributing Editor Ajai Chari, MD, a professor of clinical medicine and director of the myeloma program at the University of California San Francisco, talks with Pieter Sonneveld, MD, PhD, a professor of hematology at the Erasmus University of Rotterdam in the Netherlands. They discuss Dr. Sonneveld’s recent paper, “Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma,” published in The New England Journal of Medicine. Dr. Chari wrote about Dr. Sonneveld’s paper in The Hematologist with his Diffusion article, “Four Is Better Than Three: Will We Finally Agree?”

Disclosures: Dr. Chari has received consulting fees from Abbvie, Adaptive, Amgen, Antengene, Bristol Myers Squibb, Forus, Genentech/Roche, Glaxo Smith Klein, Janssen, Karyopharm, Millenium/Takeda, and Sanofi/Genzyme and received research funding from Janssen. Dr. Sonneveld has served on the advisory board of Pfizer and has received research funding and served on the advisory boards of Amgen, Bristol Myers Squibb, Celgene, Janssen, and Karyopharm.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Toward Equity in Access for ALL

The Hematologist — Tue, 30 Jan 2024 13:18:53 -0500

In this episode, Contributing Editor Lori Muffly, MD, an associate professor of medicine specializing in blood and marrow transplantation and cellular therapies at Stanford University in California, talks with Roberta Demichelis, MD, an assistant professor in the department of hematology and oncology at the Salvador Zubirán National Institute of Health Sciences and Nutrición in Mexico City. They discuss access to care for patients with acute lymphoblastic leukemia in low- and middle-income countries, especially among Hispanic populations.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

The Brilliant Success of Blinatumomab for Babies With Acute Lymphoblastic Leukemia

The Hematologist — Wed, 29 Nov 2023 14:15:16 -0500

In this episode, Contributing Editor Sarah Tasian, MD, associate professor at the University of Pennsylvania School of Medicine and chief of the hematologic malignancies program at the Children’s Hospital of Philadelphia, talks with Rob Pieters, MD, the chief medical officer at the Princess Maxima Center for Pediatric Oncology and professor of pediatric oncology at the University of Utrecht, both in Utrecht, Netherlands. Dr. Pieters is one of the authors of a paper published recently in The New England Journal of Medicine: “Blinatumomab Added to Chemotherapy in Infant Lymphoblastic Leukemia.”

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Editors-in-Chief of Two New ASH Journals Share Their Visions

The Hematologist — Fri, 20 Oct 2023 16:27:54 -0400

In this episode, Dr. Shaji Kumar, editor-in-chief of The Hematologist, has a conversation with Drs. Jonathan Licht and Keith McCrae, the editors-in-chief, respectively, of ASH's two new journals Blood Neoplasia and Blood Vessels, Thrombosis & Hemostasis.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

ASH’s Minority Recruitment Initiative Mentorship Program Offers a Win for All

The Hematologist — Mon, 18 Sep 2023 12:57:29 -0400

In this episode, Dr. Satiro De Oliveira talks about his own experience with the mentorship program within ASH’s Minority Recruitment Initiative and its impact on trainees coming from underrepresented groups. Dr. De Oliveira is an associate professor in the Division of Pediatric Hematology Oncology at UCLA.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Results From the Blood and Marrow Transplant Trials Network: How Should We Prevent Graft-versus-host Disease in 2023?

The Hematologist — Fri, 01 Sep 2023 09:43:06 -0400

In this episode, Contributing Editor Kate Markey, MBBS, PhD, talks with Shernan Holtan, MD, one of the authors of a paper published recently in The New England Journal of Medicine: “Post-transplantation Cyclophosphamide-based Graft-versus-host Disease Prophylaxis.”

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Genetic Background Influences the Growth of CHIP Clones Within the Bone Marrow, With Drs. Robert Hasserjian and Siddhartha Jaiswal

The Hematologist — Fri, 07 Jul 2023 11:54:31 -0400

In this episode, Contributing Editor Dr. Robert Hasserjian has a conversation with Dr. Siddhartha Jaiswal about a recent paper Dr. Jaiswal co-authored: “Aberrant activation of TCL1A promotes stem cell expansion in clonal haematopoiesis.”

Dr. Hasserjian is a professor of pathology at Harvard Medical School. He is also the director of the Hematopathology Fellowship Program at Massachusetts General Hospital. Dr. Jaiswal is an assistant professor of pathology at Stanford University School of Medicine.

Dr. Hasserjian wrote about Dr. Jaiswal’s paper in his recent Diffusion article in The Hematologist. You can access his Diffusion article online at: https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V20.4.202344/496652/Genetic-Background-Influences-the-Growth-of-CHIP

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Drawing New Blood Into Hematology

The Hematologist — Fri, 16 Jun 2023 15:13:41 -0400

In this episode, Drs. Robert Stern and Ronak Mistry talk about their own professional journeys as hematologists, why they love what they do, the medical education for hematologists, and recruitment efforts to bring more students into the field.

Dr. Stern is the associate program director with the Dana-Farber Massachusetts General Brigham Fellowship in Hematology and Oncology in Boston.

Dr. Mistry is a clinical fellow in the division of hematology and oncology at Vanderbilt University Medical Center in Nashville.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Anticoagulation and Abnormal Uterine Bleeding: Acknowledging Calls to Action

The Hematologist — Thu, 18 May 2023 10:24:08 -0400

In this episode, Contributing Editor Dr. Michael Scott is joined by Dr. Sumedha Arya for a conversation with Dr. Cindy de Jong. They discuss a study covered by Drs. Scott and Arya in their recent Diffusion article titled “Anticoagulation and Abnormal Uterine Bleeding: Acknowledging Calls to Action.” Dr. de Jong performed analysis for the study and served as one of the lead authors of the paper published in Blood. To access the Diffusion article online, please click here.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

ASH | FDA Collaboration: A Workshop on Regulatory Science in Hematology

The Hematologist — Fri, 21 Apr 2023 14:22:12 -0400

In this installment, Dr. Nicole Gormley and Dr. Grzegorz Nowakowski discuss a collaboration between ASH and the FDA that led to a successful workshop on regulatory science in hematology, an event they co-chaired and one that will return Oct. 10–11 at ASH headquarters in Washington, D.C. Dr. Gormley, a hematologist with the FDA, is the Division Director for the Division of Hematologic Malignancies 2 and the Acting Associate Director for Oncology Endpoint Development within the Oncology Center of Excellence. Dr. Nowakowski is a hematologist at the Mayo Clinic Rochester where he serves as the Deputy Cancer Center Director for Clinical Research. Dr. Nowakowski also serves as Chair of the ASH Subcommittee on Clinical Trials.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

The Next Wave of T-cell Engagement for the Management of Diffuse Large B-cell Lymphoma, with Drs. Michael Dickinson and Loretta J. Nastoupil

The Hematologist — Tue, 04 Apr 2023 12:42:38 -0400

In this installment, Contributing Editor Dr. Loretta J. Nastoupil has a conversation with Dr. Michael Dickinson. They discuss the New England Journal of Medicine article covered by Dr. Nastoupil in her most recent Diffusion article titled, “The Next Wave of T-cell Engagement for the Management of Diffuse Large B-cell Lymphoma.” In the article, Dr. Nastoupil discusses a study that looks at a promising therapy for the management of diffuse large B-cell lymphoma. Read more

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

VTE Guidelines for Latin America Special Populations and Diagnosis (Portuguese Audio)

The Hematologist — Wed, 22 Mar 2023 10:39:30 -0400

Nesta segunda parte de nossa serie sobre a adaptação das Diretrizes de Prática Clínica da ASH sobre tromboembolismo venoso na América Latina, Dra. Suely Meireles Rezende e Dr. Daniel Días Ribeiro discutem a publicação das diretrizes para prevenção de tromboemboilsmo venoso em pacientes na América Latina. Este podcast é a versão em português de uma série especial com episódios em inglês, espanhol e português.

Daniel Días Ribeiro, Médico hematologista e Patologista Clínico, Mestre e Doutor pela Faculdade de Medicina – UFMG, Doutor em Epidemiologia Clínica pela Leiden University Medical Center.

Dr. Suely Meireles Rezende, Médica hematologista, Professora associada da Faculdade de Medicina da universidade federal de Minas Gerais, representando a Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular.

Nossos participantes declararam não ter conflito de interesse com empresas que fabricam e vendem medicamentos ou dispositivos para diagnosticar ou tratar tromboemboilsmo venoso.

Visite www.hematology.org/vte para obter mais informações sobre as diretrizes.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

VTE Guidelines for Latin America Special Populations and Diagnosis (Spanish Audio)

The Hematologist — Wed, 22 Mar 2023 10:37:59 -0400

En este episodio de nuestra serie sobre las Guías de Práctica Clínica de ASH, la Dra. Pamela Zuñiga y el Dr. Pedro Pablo García Lázaro Guillermo conversan sobre la importancia clínica de las nuevas Guías de ASH para el Manejo del Tromboembolismo Venoso para América Latina. Este podcast es la versión en español de una serie especial de tres partes con episodios en inglés, español, y portugués.

La Dra. Pamela Zuñiga es hematóloga en la Pontificia Universidad Católica de Chile y participante del Panel LATAM ASH VTE en representación de la Sociedad Chilena de Hematología.

El Dr. Pedro Pablo García Lázaro es hematólogo en la Universidad Privada Antenor Orrego y el Hospital Especializado Víctor Lazarte Echegaray, y participante del Panel LATAM ASH VTE en representación de la Sociedad Peruana de Hematología.

Nuestros participantes han declarado que no tienen conflicto de interés financiero directo alguno con compañías que desarrollan y venden drogas o dispositivos para diagnosticar o tratar tromboembolismo venoso.

Visite www.hematology.org/vte para obtener más información sobre las guías.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

VTE Guidelines for Latin America Special Populations and Diagnosis (English Audio)

The Hematologist — Wed, 22 Mar 2023 10:36:55 -0400

In this installment of our ASH Clinical Practice Guidelines series, Dr. Luis Meillon and Dr. Jaime Pereira have a conversation about the clinical importance of new ASH Guidelines on Venous Thromboembolism in Latin America. This podcast is the English version of a dedicated three-part series in English, Spanish, and Portuguese.

Dr. Luis Meillon is a hematologist at the ABC Medical Center and panel member representing the Sociedad Mexicana de Trombosis y Hemostasia. He is President of the Agrupación Mexicana para el Estudio de la Hematología.

Dr. Pereira is Professor at the Department of Hematology-Oncology, School of Medicine, Catholic University of Chile and member of the Latin American panel for ASH VTE Guidelines on behalf of the Chilean Society of Hematology.

None of our speakers has a direct financial conflict of interest with companies that market drugs or devices used to diagnose or treat VTE.

For more information on ASH Guidelines, and how you can get involved, visit www.hematology.org/guidelines. Send in your comments to quality@hematology.org.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

ASH Summit on Immunotherapies for Hematologic Diseases, With Dr. Terry Fry and Dr. Shaji Kumar

The Hematologist — Thu, 16 Feb 2023 11:19:36 -0500

In this installment, 2023 ASH Summit on Immunotherapies for Hematologic Diseases co-chair Dr. Terry Fry, and The Hematologist Editor-in-Chief Dr. Shaji Kumar have a conversation about what attendees can expect for this year’s summit, taking place in-person only. They discuss the current progress of immunotherapies for treating hematologic malignancies, some of the limitations to bringing these kinds of therapies to patients, manufacturing and regulatory issues, management of toxicities, and more, all to be specifically addressed during the summit.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

GPRC5D: The Next Frontier for Immunotherapy in Multiple Myeloma, With Drs. Shaji Kumar and Saad Usmani

The Hematologist — Fri, 20 Jan 2023 11:55:39 -0500

In this installment, The Hematologist Editor-in-Chief Dr. Shaji Kumar has a conversation with Contributing Editor Dr. Saad Usmani. They discuss Dr. Usmani’s Year’s Best coverage in which he describes the past year’s breakthroughs in immunotherapies for multiple myeloma. The focus in particular on B-cell maturation antigen (BCMA) –targeted therapies, including chimeric antigen receptor T-cells (CAR-Ts) and bispecific T-cell engagers. The editors discuss data presented as recently as the 2022 ASH Annual Meeting, as well as issues surrounding toxicity, patient relapse, and the future of bispecifics and CAR-Ts.

You can access his article online at
https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V20.1.202314/494129/GPRC5D-The-Next-Frontier-for-Immunotherapy-in
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Should Minimal Residual Disease Guide the Way? With Drs. Partow Kebriaei and Lori Muffly

The Hematologist — Tue, 10 Jan 2023 15:58:47 -0500

In this installment, Contributing Editor Dr. Lori Muffly has a conversation with Dr. Partow Kebriaei. They discuss the Blood article covered by Dr. Muffly in her most recent Diffusion article titled, “Should Minimal Residual Disease Guide the Way? The Evolving Role of Allogeneic Hematopoietic Cell Transplantation for Adults With Ph+ Acute Lymphoblastic Leukemia in First Complete Remission.” In the article, Dr. Muffly explored the study by Drs. Ghobadi, Kebriaei, and colleagues, which examined the impact of allogeneic hematopoietic cell transplantation in adults with Ph+ acute lymphoblastic leukemia achieving deep molecular remission.
You can access his Diffusion article online at https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V19.6.202267/486876/Should-Minimal-Residual-Disease-Guide-the-Way-The.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

ASH Celebrates Hispanic Heritage Month, With Drs. Ruben Mesa, Diego Adrianzen-Herrera, & Joanna Robles, Introduced by Dr. Belinda Avalos

The Hematologist — Thu, 22 Sep 2022 17:00:00 -0400

In this installment, Dr. Ruben Mesa leads a conversation in honor of Hispanic Heritage Month, in an interview with Dr. Diego Adrianzen-Herrera and Dr. Joanna Robles. They share their experiences as hematologists of Hispanic/LatinX heritage and discuss the role of mentorship and ASH in their work, what led them to their careers in medicine, and what they as individuals can do to ensure the Hispanic/LatinX community has a voice in the field. Contributing a special introduction to the conversation is Dr. Belinda Avalos, an outspoken leader in diversity, equity, and inclusion in hematology. For more information on the Society's diversity, equity, and inclusion efforts, please visit www.hematology.org/DEI.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

ASH Celebra el Mes de la Herencia Hispana, Con el Dr. Ruben Mesa, el Dr. Diego Adrianzen-Herrera, & la Dra. Joanna Robles

The Hematologist — Thu, 22 Sep 2022 17:00:00 -0400

En este episodio, el Dr. Rubén Mesa entrevista al Dr. Diego Adrianzen-Herrera y la Dra. Joanna Robles en honor del Mes de la Herencia Hispana sobre sus experiencias como hematólogos de ascendencia hispana/latina, la importancia de ASH y un buen mentor en sus carreras, lo que los llevó a estudiar medicina, y la forma de garantizar que la comunidad hispana tenga una voz en el sector de la hematología. Para obtener información adicional, visite www.hematology.org/DEI.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Iron-restricted Erythropoiesis in Sickle Cell Disease, With Drs. David Rees, Naja Nyffenegger, & Vania Manolova

The Hematologist — Wed, 21 Sep 2022 09:00:00 -0400

In this installment, Contributing Editor Dr. David Rees has a conversation with Drs. Naja Nyffenegger and Vania Manolova. They discuss the Blood article covered by Dr. Rees in his most recent Diffusion article titled, “Iron-restricted Erythropoiesis in Sickle Cell Disease.” In the article, Dr. Rees explored the study by Dr. Nyffenegger and colleagues, which hypothesized that iron restriction via blocking ferroportin might reduce sickle hemoglobin concentration in red blood cells, thereby decreasing hemolysis, improving blood flow, and preventing vaso-occlusive events. You can access his Diffusion article online at https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V19.5.202256/486443/Iron-restricted-Erythropoiesis-in-Sickle-Cell.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

ASH and Maternal Health, With Drs. Jennifer Holter-Chakrabarty & Sarah O’Brien

The Hematologist — Mon, 19 Sep 2022 09:00:00 -0400

In this episode, Dr. Jennifer Holter-Chakrabarty, chair of the ASH Committee on Government Affairs, and Dr. Sarah O’Brien, chair of the ASH Working Group on Maternal Health in Hematology have a conversation about recent issues facing maternal health care, and what the Society and its membership is doing to confront these challenges, through advocacy and education.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Trust Your Gut: Changes in Intestinal Microbiome Are Associated With Outcomes Following CAR-T Therapy, With Drs. Loretta Nastoupil & Melody Smith

The Hematologist — Fri, 01 Jul 2022 08:00:00 -0400

In this installment, Contributing Editor Dr. Loretta Nastoupil has a conversation with Dr. Melody Smith. They discuss a Nature Medicine article covered by Dr. Nastoupil in her most recent Diffusion article titled, “Trust Your Gut: Changes in Intestinal Microbiome Are Associated With Outcomes Following CAR-T Therapy.” In the article, Dr. Nastoupil discusses a study that explored whether antibiotic exposure or fecal microbiome composition was associated with efficacy and toxicity following anti-CD19 chimeric antigen receptor T-cell therapy in adult patients with B-cell malignancies. You can access her Diffusion article online at https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V19.4.202247/485636/Trust-Your-Gut-Changes-in-Intestinal-Microbiome.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

The Latest Sickle Cell Disease Policy Updates, With Drs. Jennifer Holter Chakrabarty & Chancellor Donald

The Hematologist — Wed, 01 Jun 2022 08:00:00 -0400

In this installment, ASH Committee on Practice Chair Dr. Chancellor Donald and ASH Committee on Government Affairs Chair Dr. Jennifer Holter Chakrabarty provide an overview of the latest sickle cell disease (SCD) policy updates and highlight ASH's work to date on the Hill, including a recently introduced SCD bill, and work with the U.S. Department of Health and Human Services and other federal partners. Learn more and get involved by visiting www.hematology.org/advocacy.
PLEASE NOTE: During their conversation, Drs. Donald and Holter Chakrabarty discuss the Sickle Cell Disease Comprehensive Care Act (H.R. 6216/S. 3389), bipartisan legislation introduced in December 2021 that seeks to create a demonstration program in up to 10 states to improve access to comprehensive, high-quality, outpatient care for individuals with SCD enrolled in Medicaid. Dr. Holter Chakrabarty mentions a number of specific states that may benefit if the legislation passes Congress and is signed into law. We would like to clarify that none of the states Dr. Holter Chakrabarty mentions are guaranteed participation in the demonstration program. However, under the guidelines set forth in the legislation, priority for participation will be given to states that participate in the Centers for Disease Control and Prevention (CDC) Sickle Cell Data Collection program (which the states mentioned by Dr. Holter Chakrabarty are all participants in), as well as states with a high prevalence of individuals living with SCD.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Structural Racism and Understanding Disparities in AML Outcomes, With Drs. Christine McMahon & Ivy Abraham

The Hematologist — Tue, 03 May 2022 09:48:21 -0400

In this installment, Contributing Editor Dr. Christine McMahon has a conversation with Dr. Ivy Abraham. They discuss a Blood article covered by Dr. McMahon in her most recent Diffusion article titled, “Toward Understanding Disparities in AML Outcomes: The Role of Structural Racism.” In the article, Dr. McMahon discusses an analysis of data showing disparities in acute myeloid leukemia (AML) outcomes among racial and ethnic groups as well as the reason these disparities exist. You can access her Diffusion article online at https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V19.3.202239/484980/Toward-Understanding-Disparities-in-AML-Outcomes.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

A Conversation About Women in Medicine, With Drs. Shikha Jain and Laura Michaelis

The Hematologist — Wed, 13 Apr 2022 09:00:00 -0400

In this installment, Editor-in-Chief Dr. Laura Michaelis interviews Dr. Shikha Jain. In this interview, Dr. Michaelis and Dr. Jain chat about female physicians' experience in the workforce, women in medicine, and discuss a series of articles and studies on why they are leaving the workforce and how their experiences compare to their male counterparts. Visit the ASH website to learn about the Society's Women in Hematology Working Group's efforts via https://www.hematology.org/diversity-equity-and-inclusion/women-in-hematology-working-group.
About Dr. Jain:
Dr. Jain’s clinical focus is GI oncology with a special interest in neuroendocrine tumors, colorectal cancer, and hepatocellular carcinoma (liver cancer). Her research interests include neuroendocrine tumors, immunotherapy, colorectal and pancreatic cancers, hepatocellular carcinoma advances in cancer therapy, the impact of social media in medicine, health care communication, and health care and gender equity. She works to incorporate patient education and outreach in her patients’ treatment and believes in personalized and individualized care. Dr. Jain founded and is the CEO of the COVID-19 action and advocacy group IMPACT. She founded and co-chaired the inaugural Women in Medicine Symposium at Northwestern Memorial Hospital in Chicago in 2018, which focused on promoting the advancement of women physicians at Northwestern. She is co-founder of the Rush Center for the Advancement of Women in Health Care. Learn more about her accomplishments and work at https://shikhajainmd.com/.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

ASH VTE-LA Guidelines: Prevention of VTE in Latin America, With Drs. Patricia Casais & Luis Meillon-Garcia

The Hematologist — Thu, 17 Mar 2022 14:00:00 -0400

English Version: In this podcast, 2022 ASH Guidelines for Prevention of Venous Thromboembolism in Latin American panel members Dr. Patricia Casais and Dr. Luis Meillon-Garcia have a conversation about the clinical importance of new Guidelines on Venous Thromboembolism in Latin America in medical and surgical patients and long-distance travelers in Latin America. Learn more by visiting www.hematology.org/vte, and read the full guideline in a Blood Advances publication via https://ashpublications.org/bloodadvances/article/doi/10.1182/bloodadvances.2021006482/484109/ASH-ABHH-ACHO-Grupo-CAHT-Grupo-CLAHT-SAH-SBHH-SHU.
Additional membership and affiliation information for our speakers: Dr. Patricia Casais is a panel member of the ASH, ABHH, ACHO, Grupo CAHT, Grupo CLAHT, SAH, SBHH, SHU, SOMETH, Sociedad Panameña de Hematología, SPH, SVH, 2022 Guidelines for Prevention of VTE in Latin America. Dr. Luis Meillon-Garcia is a member of the academic board of SOMETH (Sociedad Mexicana de Trombosis y Hemostasia).
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Modelling Myelofibrosis in Vivo: Success With NSG-S, With Drs. Beth Psaila and Hamza Celik

The Hematologist — Fri, 04 Mar 2022 09:00:00 -0500

In this podcast, Contributing Editor Dr. Beth Psaila has a conversation with Dr. Hamza Celik. They discuss a Cancer Discovery article covered by Dr. Psaila in her most recent Diffusion article titled, “Modeling Myelofibrosis in Vivo: Success With NSG-S.” In the article, Dr. Psaila discusses an optimized approach for engrafting myelofibrosis CD34+ stem/progenitor cells from peripheral blood of patients into immunodeficient mice called NSG-S, as a successful model of myelofibrosis in an in vivo setting. You can access her Diffusion article online at https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V19.2.202222/484169/Modelling-Myelofibrosis-in-Vivo-Success-With-NSG-S.
Additional information about Dr. Celik: Dr. Hamza Celik joined Incyte Research Corporation in 2020 as a principal investigator in pre-clinical pharmacology. At the time he contributed to the article referenced in Dr. Psaila’s Diffusion and in this podcast, he was in the process of completing his postdoctoral work in normal and malignant hematopoiesis under the supervision of Dr. Grant Challen at the Washington University of St. Louis.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Guías TEV-LA: Prevención de TEV en América Latina, Con Dras. Cecilia Colorio y Cecilia Guillermo

The Hematologist — Fri, 25 Feb 2022 08:00:00 -0500

Spanish Version/Versión en Español: En este pódcast, miembros del Panel LATAM ASH TEV, Dra. Cecilia Colorio y Dra. Cecilia Guillermo, conversan sobre la importancia clínica de las nuevas Guías Para la Prevención del Tromboembolismo Venoso para América Latina, en pacientes quirúrgicos, médicos, y viajeros de larga distancia. Visite www.hematology.org/vte para mٔás información y lea las guías completas en una publicación de Blood Advances: https://ashpublications.org/bloodadvances/article/doi/10.1182/bloodadvances.2021006482/484109/ASH-ABHH-ACHO-Grupo-CAHT-Grupo-CLAHT-SAH-SBHH-SHU.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Diretrizes TEV-LA: Prevenção de TEV na América Latina, Com Dr. Suely Rezende e Daniel Ribeiro

The Hematologist — Fri, 25 Feb 2022 06:00:00 -0500

Portuguese Version/Versão em Português: Neste podcast, Doutora Suely Rezende e Doutor Daniel Ribeiro, membros do Painel LATAM ASH TEV, conversam sobre a importância clínica das novas Diretrizes Para a Prevenção do Tromboembolismo Venoso em pacientes cirúrgicos e hospitalizados, e viajantes de longa distância na América Latina. Visite www.hematology.org/vte para mais informações e leia as diretrizes completas na publicação da Blood Advances: https://ashpublications.org/bloodadvances/article/doi/10.1182/bloodadvances.2021006482/484109/ASH-ABHH-ACHO-Grupo-CAHT-Grupo-CLAHT-SAH-SBHH-SHU.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

An Interview With Pediatric Physician Scientist, Advocate, and Mentor Dr. Rayne Rouce

The Hematologist — Wed, 09 Feb 2022 08:00:00 -0500

In this installment, Editor-in-Chief Dr. Laura Michaelis interviews Dr. Rayne Rouce. Amazing doctors are leading the way for a future generation of hematologists through their inspiring work and intentional commitment to make a positive change in the medical field. In this interview, Dr. Michaelis and Dr. Rouce chat about Dr. Rouce’s work with children as a pediatric hematologist/oncologist, in the lab, her work with advocacy and promoting diversity in health care, and her passion for music that has led to a rap career inspiring youth.
Dr. Rayne Rouce is an avid volunteer who has dedicated her professional and personal life to enhancing the lives of children with cancer and blood disorders, both within and outside the hospital. She is an avid advocate, working for 15 years with The Periwinkle Foundation’s events and programs for children with cancer and other life-threatening diseases and community engagement STEM initiatives to enhance K-12 exposure to science and medicine. Thanks to her fluency in Spanish, she has been able to not only provide comprehensive care to her patients, but has also volunteered in the past to care for children around Texas and in small villages in Bolivia. She is a member of the ASH Committee on Diversity, Equity, and Inclusion and Committee on Promoting Diversity liaison for the ASH Awards Committee. Dr. Rouce received the ASH-AMFDP Award in 2016, is an inaugural participant of the ASH Ambassador Program, and served as faculty for the 2020 and 2021 ASH Clinical Research Training Institute.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

From Myth to Reality: Achieving Second Remission in ALL, With Drs. Kristen O'Dwyer & Laura Michaelis

The Hematologist — Thu, 13 Jan 2022 09:00:00 -0500

In this podcast, Editor-in-Chief Dr. Laura Michaelis has a conversation with Contributing Editor Dr. Kristen O'Dwyer. They discuss Dr. O'Dwyer's pick for the best of 2021 on achieving a second remission in patients with acute lymphoblastic leukemia (ALL). You can access her Year's Best article online at https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V19.1.2022110/483386/From-Myth-to-Reality-Achieving-a-Second-Remission.
Additional disclaimer: Dr. Kristen O'Dwyer contributed to/was an author on the ZUMA-3 trial.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

2021 ASH Annual Meeting: Plenary Abstract on ZUMA-7 Study, With Drs. Frederick Locke & Brad Kahl

The Hematologist — Thu, 09 Dec 2021 10:14:52 -0500

In this installment of our 2021 ASH Annual Meeting Podcast series, Contributing Editor Dr. Brad Kahl has a conversation with Contributing Editor Dr. Frederick Locke about his work on one of the plenary abstracts that will be presented at the 2021 ASH Annual Meeting. The abstract presents an analysis of the ZUMA-7 trial of axicabtagene ciloleucel versus standard-of-care therapy in patients with relapsed/refractory large B-cell lymphoma.
For coverage of the plenary scientific session, including this abstract and many other sessions, check www.ashpublications.org/ashnewsdaily throughout the meeting.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

2021 ASH Annual Meeting: COVID-19 Content at the Meeting, With Drs. Cindy Dunbar and Laura Michaelis

The Hematologist — Tue, 07 Dec 2021 09:18:04 -0500

In this installment of our 2021 ASH Annual Meeting Podcast series, Editor-in-Chief Dr. Laura Michaelis has a conversation with ASH Secretary Dr. Cindy Dunbar about the COVID-19–related content that will be presented at the 2021 ASH Annual Meeting.
For coverage of abstracts, sessions, and other events, check www.ashpublications.org/ashnewsdaily throughout the meeting. Visit www.hematology.org/covid-19 for a list of related sessions at this year's meeting.

While we regularly review and update the links, resources, and FAQs posted on the ASH website to reflect the best information available at a given point in time, the COVID-19 pandemic is a rapidly evolving global health crisis. Please take note of the dates of publication for each podcast.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

2021 ASH Annual Meeting: Plenary Abstract on ATLAS-INH in Patients With Hemophilia A or B With Inhibitors, Drs. Guy Young & Laura Michaelis

The Hematologist — Thu, 02 Dec 2021 09:38:40 -0500

In this installment of our 2021 ASH Annual Meeting Podcast series, Editor-in-Chief Dr. Laura Michaelis has a conversation with Dr. Guy Young about his work on one of the plenary abstracts that will be presented at the 2021 ASH Annual Meeting. The abstract evaluates the efficacy and safety of fitusiran prophylaxis in a multicenter phase 3 study (ATLAS-INH) in patients with hemophilia A or B with inhibitors.
For coverage of the plenary scientific session, including this abstract and many other sessions, check www.ashpublications.org/ashnewsdaily throughout the meeting.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Weighing the Risks and Benefits of DOACs in Morbidly Obese Patients, With Drs. Damon Houghton & Karlyn Martin

The Hematologist — Mon, 01 Nov 2021 09:00:00 -0400

In this podcast, Contributing Editor Dr. Damon Houghton has a conversation with Dr. Karlyn Martin. They discuss a Journal of Thrombosis and Haemostasis article covered by Dr. Houghton in his most recent Diffusion article titled, “Weighing the Risk and Benefits of Direct Oral Anticoagulants in Morbidly Obese Patients: New Data and Guidance.” In the article, Dr. Houghton discusses the updated recommendations from the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee Subcommittee on Control of Anticoagulation on the use of direct oral anticoagulants in patients with obesity for the treatment and prevention of venous thromboembolism. You can access his Diffusion article online at: https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V18.6.2021610/477245/Weighing-the-Risk-and-Benefits-of-Direct-Oral.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

ASH VTE Guidelines & COVID-19 Update: Use of Anticoagulation in Patients With COVID-19, With Drs. Laura Michaelis, Adam Cuker & Reem Mustafa

The Hematologist — Fri, 01 Oct 2021 11:29:05 -0400

In this installment of our ASH Clinical Practice Guidelines and our COVID-19 series, Editor-in-Chief Dr. Laura Michaelis has a conversation with the Use of Anticoagulation in Patients with COVID-19 guideline panel co-chairs Dr. Adam Cuker and Dr. Reem Mustafa. They discuss the clinical importance of these guidelines as well as the process to track and respond to the ongoing emergence of new clinical data and evidence. For more information on these guidelines, and how you can get involved, visit www.hematology.org/VTEguidelines and for additional constantly-updated COVID-19 resources, visit www.hematology.org/covid-19.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Genome Editing: Fetal Origins of AML in Down Syndrome, With Drs. Adam Mead & Elvin Wagenblast

The Hematologist — Fri, 17 Sep 2021 13:22:24 -0400

In this podcast, Contributing Editor Dr. Adam Mead has a conversation with Dr. Elvin Wagenblast. They discuss Dr. Mead’s Diffusion article from the September/October 2021 issue of The Hematologist, titled, "Genome Editing: The Fetal Origins of Acute Myeloid Leukemia in Down Syndrome." They discuss a study that used CRISPR/Cas9 genome editing of hematopoietic stem and progenitor cells from human fetal liver to induce transient abnormal myelopoiesis– and myeloid leukemia associated with Down syndrome–related mutations. You can access his Diffusion article online at https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V18.5.202159/476568/Genome-Editing-the-Fetal-Origins-of-Acute-Myeloid.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Diretrizes TEV-LA: Gestão de TEV na América Latina, Com Dr. Suely Rezende e Daniel Ribeiro

The Hematologist — Wed, 01 Sep 2021 11:00:35 -0400

Neste podcast, Doutora Suely Rezende e Doutor Daniel Ribeiro, membros do Painel LATAM ASH TEV, conversam sobre a importância clínica das novas Diretrizes Para o Tratamento do Tromboembolismo Venoso na América Latina. Visite www.hematology.org/vte para mais informações e leia as diretrizes completas na publicação da Blood Advances: https://ashpublications.org/bloodadvances/article/5/15/3032/476514/ASH-ABHH-ACHO-Grupo-CAHT-Grupo-CLAHT-SAH-SBHH-SHU?searchresult=1. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Guías TEV-LA: Manejo de TEV en América Latina, Con Dras. Cecilia Colorio y Cecilia Guillermo

The Hematologist — Wed, 25 Aug 2021 11:00:25 -0400

Spanish Version/Versión Español: En este pódcast, miembros del panel Panel LATAM ASH TEV, Dra. Cecilia Colorio y Dra. Cecilia Guillermo, conversan sobre la importancia clínica de las nuevas Guías Para el Manejo del Tromboembolismo Venoso para América Latina. Visite www.hematology.org/vte para mٔás información y lea las guías completas en una publicación de Blood Advances: https://ashpublications.org/bloodadvances/article/5/15/3032/476514/ASH-ABHH-ACHO-Grupo-CAHT-Grupo-CLAHT-SAH-SBHH-SHU?searchresult=1. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

ASH VTE-LA Guidelines: Management of VTE in Latin America, Drs. Patricia Casais & Guillermo León

The Hematologist — Wed, 18 Aug 2021 11:00:15 -0400

English Version: In this podcast, 2021 ASH Guidelines for Management of Venous Thromboembolism in Latin American panel members Dr. Patricia Casais and Dr. Guillermo León Basantes have a conversation about the clinical importance of new Guidelines on Venous Thromboembolism in Latin America. Learn more by visiting www.hematology.org/vte, and read the full guideline in a Blood Advances publication via https://ashpublications.org/bloodadvances/article/5/15/3032/476514/. Additional membership and affiliation information for our speakers: Dr. Patricia Casais is a panel member of the ASH, ABHH, ACHO, Grupo CAHT, Grupo CLAHT, SAH, SBHH, SHU, SOMETH, Sociedad Panameña de Hematología, SPH, SVH, 2021 Guidelines for Management of Venous Thromboembolism in Latin America. Dr. Guillermo León Basantes is a member of the ACHO (Colombian Association of Oncology and Hematology) and Grupo CLATH.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Coming Soon: 3-Part Podcast Series on ASH VTE Guidelines in Latin America

The Hematologist — Wed, 11 Aug 2021 11:00:05 -0400

Coming Soon: In an upcoming installment of our ASH Clinical Practice Guidelines series, panel members from the 2021 Guidelines for the Management of Venous Thromboembolism in Latin America will discuss the clinical importance of the new guidelines on VTE in Latin America. Join us each week for new episodes in English, Spanish, and Portuguese featuring panel members discussing the contextual factors for why these recommendations are so important to clinicians, patients, and other key stakeholders. Find additional information by visiting www.hematology.org/vte. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

The ASH Journal Club, With Drs. Olga Guryanova and Andrew Volk

The Hematologist — Mon, 02 Aug 2021 09:01:57 -0400

In this installment of The Hematologist podcast, members of the ASH Taskforce on PhD Careers in Hematology Dr. Olga Guryanova and Dr. Andrew Volk have a conversation about the ASH Journal Club, a new series that will highlight seminal papers in hematology published in Blood and Blood Advances, featuring a manuscript author and moderated discussion. Learn more by visiting https://www.hematology.org/about/careers/resources-for-phds and Access the Journal Club via https://academy.hematology.org/local/catalog/view/product.php?productid=1170. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Immune Therapies for Myeloma, With Drs. Saad Usmani and Nikhil Munshi

The Hematologist — Thu, 01 Jul 2021 11:09:45 -0400

In this podcast, Contributing Editor Dr. Saad Usmani has a conversation with Dr. Nikhil Munshi. They discuss Dr. Usmani’s Mini Review article from the July/August 2021 issue of The Hematologist, titled, "Immune Therapies for Myeloma: The CARs Are Here but What’s Next?" They discuss the latest approvals of chimeric antigen receptor T-cell therapies to treat multiple myeloma. You can access her Mini Review article online at https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V18.4.2021413/476193/Immune-Therapies-for-Myeloma-The-CARs-Are-Here-but?utm_source=sfmc&utm_medium=email&utm_campaign=TheHem+July+2021&utm_term=Link+Text+%c2%bb&utm_id=102625&sfmc_id=32555314. Additional ASH affiliation and COI information: Dr. Usmani has received research funding from Amgen, Array Biopharma, BMS, Celgene, GSK, Janssen, Merck, Pharmacyclics, Sanofi, Seattle Genetics, SkylineDX, and Takeda; consulting fees from Amgen, BMS, Celgene, EdoPharma, GSK, Janssen, Sanofi, Seattle Genetics, SecuraBio, SkylineDX, Takeda, and TeneoBio; speaker fees from Amgen, BMS, Janssen, and Sanofi. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Chemotherapy Drug Shortages in Pediatric Oncology, With Drs. Sarah Tasian and Yoram Unguru

The Hematologist — Mon, 28 Jun 2021 11:24:17 -0400

In this podcast, Contributing Editor Dr. Sarah Tasian has a conversation with Dr. Yoram Unguru. They discuss Dr. Tasian’s Feature article from the July/August 2021 issue of The Hematologist, titled, "Chemotherapy Drug Shortages in Pediatric Oncology: A Global Public Health Crisis Threatening Our Children." They shed light on chemotherapy drug shortages currently affecting pediatric cancer patients. You can access her Feature article online at https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V18.4.2021412/476169/Chemotherapy-Drug-Shortages-in-Pediatric-Oncology. Additional ASH affiliation and COI information: Dr. Sarah Tasian serves on the Educational Program Advisory Panel for the 2021 ASH Annual Meeting and is a member of the Scientific Committee on Blood Disorders in Childhood. Dr. Tasian receives/d research funding from Incyte Corporation and Gilead Sciences and serves on the scientific advisory boards for Aleta Biotherapeutics and Kura Oncology. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

COVID-19 Update 19: Infection in CLL Patients & Vaccine Response, Drs. Cindy Dunbar & John Gribben

The Hematologist — Tue, 15 Jun 2021 12:44:23 -0400

In this installment of our special COVID-19 podcast series, ASH Secretary Dr. Cindy Dunbar has a conversation with Dr. John Gribben. They discuss COVID-19 infection in patients with chronic lymphocytic leukemia or indolent lymphoma, including outcomes of infection, impact of CLL status and of treatment, changes to treatment approaches in the context of the pandemic, and the issues surrounding SARS-CoV-2 vaccine in these patients. Find additional ASH resources available to help the hematology community be prepared and proactive during the COVID-19 public health crisis, by visiting www.hematology.org/COVID-19. The article written by Drs. Martin Tallman and Jane Winter, mentioned by Dr. Dunbar in this podcast, is the July/August 2021 Presidents' Column for The Hematologist, and can be found online via https://ashpublications.org/thehematologist/article/476104/Masking-Vaccination-and-Research-Needed-to-Protect. If you have recommendations for topics to cover in this podcast series, please email us at thehematologist@hematology.org.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

The ASH Hematology Review Series, With Drs. Leidy Isenalumhe and Lachelle Dawn Weeks

The Hematologist — Tue, 08 Jun 2021 16:33:42 -0400

In this installment of The Hematologist podcast, Chair of the ASH Hematology Review Series Task Force Dr. Leidy Isenalumhe and Chair of the ASH Trainee Council Dr. Lachelle Dawn Weeks have a conversation about the ASH Hematology Review Series, a free series designed for fellows preparing to take the internal medicine hematology certification examination or those desiring a comprehensive update. Learn more by visiting https://www.hematology.org/education/trainees/hematology-review-series. Access the review series via https://academy.hematology.org/local/catalog/view/product.php?productid=1171; you will be asked to create an account on the ASH Academy website. Additional affiliations: Dr. Isenalumhe is also a member of the ASH Committee on Education Subcommittee and was previously a member of the ASH Trainee Council from 2016-2018 and Chair from 2017-2018. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Nutrient Deficiencies Linked to Worse Outcomes in SCD, Drs. Laura Michaelis & Ify Osunkwo

The Hematologist — Mon, 17 May 2021 10:01:05 -0400

In this podcast, Editor-in-Chief Dr. Laura Michaelis has a conversation with Contributing Editor Dr. Ifeyinwa (Ify) Osunkwo. They discuss Dr. Osunkwo’s Diffusion article from the May/June 2021 issue of The Hematologist, titled, "You Are What You Don’t Eat: Micro- and Macronutrient Deficiencies Linked to Worse Outcomes in Sickle Cell Disease." They talk about the influence of nutrition on disease severity and health-related quality of life in adults with sickle cell disease. You can access her Diffusion article online at https://ashpublications.org/thehematologist/article/475637/You-Are-What-You-Don-t-Eat-Micro-and-Macronutrient. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

ASH ICAL Next-generation Sequencing Program, Drs. Peter Valk, Torsten Haferlach & Pamela Mora

The Hematologist — Thu, 01 Apr 2021 08:51:58 -0400

In this installment of The Hematologist podcast, Dr. Peter Valk and Dr. Torsten Haferlach have a conversation about ASH International Consortium on Acute Leukemia’s Next-generation Sequencing program. We will also hear from Dr. Pamela Mora about her experience as a lab tech under the mentorship of Dr. Valk. Learn more by visiting https://www.hematology.org/global-initiatives/international-consortium-on-acute-leukemia. Find additional information on ASH global programs at www.hematology.org/global-initiatives. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

COVID-19 Update 18: ASH RC COVID-19 Registry for Hematology, Drs. Michaelis, Hicks, Wood, & Desai

The Hematologist — Thu, 11 Mar 2021 09:41:42 -0500

In this installment of our special COVID-19 podcast series, The Hematologist Editor-in-Chief Dr. Laura Michaelis has a conversation with Drs. Lisa Hicks, Bill Wood, and Pinkal Desai. They provide the latest updates on the ASH Research Collaborative COVID-19 Registry for Hematology, and we hear from Dr. Pinkal Desai about her experience using the registry and submitting patient data. To access the Registry, enter a case, and view data summaries, visit https://www.ashresearchcollaborative.org/s/covid-19-registry. Find additional ASH resources available to help the hematology community be prepared and proactive during the COVID-19 public health crisis, by visiting www.hematology.org/COVID-19. If you have recommendations for topics to cover in this podcast series, please email us at thehematologist@hematology.org.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

COVID-19 Update 17: COVID-19 Vaccines, With Drs. Laura Michaelis, Jeffery Auletta & Adrian Wiestner

The Hematologist — Wed, 03 Mar 2021 12:04:01 -0500

In this installment of our special COVID-19 podcast series, The Hematologist Editor-in-Chief Dr. Laura Michaelis has a conversation with Drs. Jeffery Auletta and Adrian Wiestner. They discuss the latest news surrounding the COVID-19 vaccine, including vaccination guidelines and frequently asked questions, as they relate to the hematology community. Find additional ASH resources available to help the hematology community be prepared and proactive during the COVID-19 public health crisis, by visiting www.hematology.org/COVID-19. If you have recommendations for topics to cover in this podcast series, please email us at thehematologist@hematology.org.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Clonal Hematopoiesis and Risk of T-MN, With Drs. Amy DeZern & Kelly Bolton

The Hematologist — Mon, 01 Mar 2021 09:20:01 -0500

In this podcast, Contributing Editor Dr. Amy DeZern has a conversation with Dr. Kelly Bolton. They discuss Dr. DeZern’s Diffusion article from the March/April 2021 issue of The Hematologist, titled, "Short-term Gain But Long-term Pain? Clonal Hematopoiesis and the Risk of Therapy-related Myeloid Neoplasms After Treatment for Solid Tumors." They discuss the relationship between clonal hematopoiesis and the risk of therapy-related myeloid neoplasms which can help tailor individualized therapy. You can access her Diffusion article online at https://ashpublications.org/thehematologist/article/475183/Short-term-Gain-But-Long-term-Pain-Clonal. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

ASH Advocacy & New Administration Health Care Priorities With Drs. Donald & Holter-Chakrabarty

The Hematologist — Tue, 16 Feb 2021 15:04:19 -0500

In this installment of The Hematologist podcast, Chair of the ASH Committee on Government Affairs Dr. Jennifer Holter-Chakrabarty and Chair of the ASH Committee on Practice Dr. Chancellor Donald have a conversation about the new Administration’s health care priorities as well as planned ASH advocacy efforts and initiatives. Learn more by visiting www.hematology.org/advocacy. Find additional ASH resources available to help the hematology community be prepared and proactive during the COVID-19 public health crisis, by visiting www.hematology.org/COVID-19. If you have recommendations for topics to cover in this podcast series, please email us at thehematologist@hematology.org. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Year's Best: The BELLINI Study, With Drs. Irene Ghobrial and Shaji Kumar

The Hematologist — Mon, 04 Jan 2021 08:54:57 -0500

In this podcast, Contributing Editor Dr. Irene Ghobrial has a conversation with Dr. Shaji Kumar. They discuss Dr. Ghobrial’s Year’s Best article from the January/February 2021 issue of The Hematologist, titled, "The BELLINI Study and the Dawn of Precision Medicine in Multiple Myeloma." They discuss a randomized, double-blinded, phase III trial testing the combination of venetoclax or placebo with bortezomib and dexamethasone in relapsed or refractory multiple myeloma. You can access her Year’s Best article online at https://ashpublications.org/thehematologist/article/474709/The-BELLINI-Study-and-the-Dawn-of-Precision. Conflicts of Interest: Dr. Kumar has received research funding for clinical trials to the institution from Abbvie, Amgen, BMS, Carsgen, Janssen, KITE, Merck, Medimmune, Novartis, Roche-Genentech, Takeda, and Tenebio, and has consulted or participated in advisory boards (with no personal payments) for Abbvie, Amgen, BMS, Janssen, Roche-Genentech, Takeda, and (with personal payment) Oncopeptides, Beigene. Dr. Ghobrial has consulted for GSK (and Advisory Board participation), Sanofi, Janssen, Takeda, Karyopharm, AbbVie, GNS (Ad. Board participation), Cellectar, Medscape, Genentech, Adaptive, BMS, Aptitude (Ad. Board participation), and Curio Science. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

2020 ASH Annual Meeting: A Guide for Trainees, With Drs. Ajay Major and Lachelle Weeks

The Hematologist — Mon, 16 Nov 2020 09:11:24 -0500

In this installment of the 2020 ASH Annual Meeting podcast series, Dr. Ajay Major and Dr. Lachelle Dawn Weeks help members of the trainee community navigate the upcoming 62nd ASH Annual Meeting. They provide important information about events and sessions of interest to the trainee community as well as features of the virtual platform that will help trainees stay connected in this new all-virtual environment. To access these resources and find additional information about what to expect, visit www.hematology.org/annual-meeting. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

2020 ASH Annual Meeting: Disparities in Science, With Drs. Laura Michaelis & Chancellor Donald

The Hematologist — Mon, 16 Nov 2020 09:10:10 -0500

In this installment of the 2020 ASH Annual Meeting podcast series, Editor-in-Chief Dr. Laura Michaelis has a conversation with Dr. Chancellor Donald. They discuss disparities in science, outcomes, and access to care, as well as planned sessions at this year’s ASH Annual Meeting that will address these topics. To access meeting resources and find additional information about what to expect, visit www.hematology.org/annual-meeting. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Is Dose-adjusted EPOCH-R Enough for Burkitt Lymphoma? With Drs. Brad Kahl and Mark Roschewski

The Hematologist — Mon, 02 Nov 2020 10:39:57 -0500

In this podcast, Contributing Editor Dr. Brad Kahl has a conversation with Dr. Mark Roschewski. They discuss Dr. Kahl's Diffusion article from the November/December 2020 issue of The Hematologist, titled, "Is Dose-adjusted EPOCH-R Enough in Burkitt Lymphoma?" They discuss a study that evaluates the efficacy of the dose-adjusted EPOCH-R regimen in adult patients with Burkitt lymphoma. You can access his Diffusion article online at https://ashpublications.org/thehematologist/article/472152/Is-Dose-adjusted-EPOCH-R-Enough-in-Burkitt. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Get Involved With ASH Advocacy, With Drs. Chancellor Donald, Alan Rosmarin, & Laura Michaelis

The Hematologist — Thu, 15 Oct 2020 09:02:26 -0400

In this installment of The Hematologist podcast and the COVID-19 podcast series, Editor-in-Chief Dr. Laura Michaelis has a conversation with Chair of the ASH Committee on Practice Dr. Chancellor Donald and Chair of the ASH Committee on Government Relations Dr. Alan Rosmarin about ASH advocacy initiatives, how advocacy has changed as a result of the COVID-19 pandemic, and how interested members can get involved in Society advocacy efforts on behalf of the hematology community. Learn more by visiting www.hematology.org/advocacy. Find additional ASH resources available to help the hematology community be prepared and proactive during the COVID-19 public health crisis, by visiting www.hematology.org/COVID-19. If you have recommendations for topics to cover in this podcast series, please email us at thehematologist@hematology.org.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

COVID-19 Update 15: The Latest ASH Resources, With Drs. Stephanie Lee and Laura Michaelis

The Hematologist — Tue, 13 Oct 2020 09:28:03 -0400

In this installment, The Hematologist Editor-in-Chief Dr. Laura Michaelis has a conversation with 2020 ASH President Dr. Stephanie Lee. They discuss the latest ASH COVID-19 resources and updates to existing ones, and how Dr. Lee has been dealing with the pandemic since we last heard from her on the very first episode in this series back in March. Find additional ASH resources available to help the hematology community be prepared and proactive during the COVID-19 public health crisis, by visiting www.hematology.org/COVID-19. If you have recommendations for topics to cover in this podcast series, please email us at thehematologist@hematology.org.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

COVID-19 Update 14: The Latest on Convalescent Plasma, With Drs. Laura Michaelis and Evan Bloch

The Hematologist — Wed, 30 Sep 2020 15:52:52 -0400

In this installment, The Hematologist Editor-in-Chief Dr. Laura Michaelis has a conversation with Dr. Evan Bloch of Johns Hopkins University School of Medicine. They discuss the latest updates on convalescent plasma. Find additional ASH resources available to help the hematology community be prepared and proactive during the COVID-19 public health crisis, by visiting www.hematology.org/COVID-19. If you have recommendations for topics to cover in this podcast series, please email us at thehematologist@hematology.org.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Does the Immune System Matter in Treatment for AML? With Drs. Steven Lane & Sergio Rutella

The Hematologist — Tue, 01 Sep 2020 09:58:44 -0400

In this podcast, Contributing Editor Dr. Steven Lane has a conversation with Dr. Sergio Rutella. They discuss Dr. Lane's Diffusion article from the September/October 2020 issue of The Hematologist, titled, "Does the Immune System Matter in Treatment for AML?" They discuss the role of the immune system in the treatment of acute myeloid leukemia. You can access his Diffusion article online at https://ashpublications.org/thehematologist/article/463586/Does-the-Immune-System-Matter-in-Treatment-for-AML. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

ASH Meeting on Hematologic Malignancies: A Virtual Experience, With Drs. Smith, Rajkumar, & Roboz

The Hematologist — Fri, 07 Aug 2020 12:18:48 -0400

In this installment, 2020 ASH Meeting on Hematologic Malignancies program co-chairs Drs. Vincent Rajkumar, Sonali Smith, and Gail Roboz have a conversation about this year’s meeting, which will be presented as a fully virtual experience. They talk about changes to in-person meetings due to COVID-19, what the new meeting format entails, and opportunities for participants to network and collaborate. Learn more by visiting www.hematology.org/meetings/hematologic-malignancies. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

COVID-19 Update 13: How Pandemic Affects Labs & Early-Career Researchers, Drs. Michaelis & Levine

The Hematologist — Tue, 23 Jun 2020 13:51:47 -0400

In this installment, The Hematologist Editor-in-Chief Dr. Laura Michaelis has a conversation with Dr. Ross Levine of Memorial Sloan Kettering Cancer Center. They discuss the ASH COVID-19 Research Agenda for Hematology, steps for getting a lab back up and running, and the effects of the pandemic on early-career researchers. Find additional ASH resources available to help the hematology community be prepared and proactive during the COVID-19 public health crisis, by visiting www.hematology.org/COVID-19. If you have recommendations for topics to cover in this podcast series, please email us at thehematologist@hematology.org.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

COVID-19 Update 12: PTSD in Health Care Providers During COVID-19, With Drs. Michaelis & Back

The Hematologist — Mon, 01 Jun 2020 09:37:02 -0400

In this installment, The Hematologist Editor-in-Chief Dr. Laura Michaelis has a conversation with Dr. Anthony Back of the University of Washington. They discuss how to mitigate post-traumatic stress disorder for providers and what health care professionals can do to promote wellness for doctors experiencing a complete change in how they practice. Find additional ASH resources available to help the hematology community be prepared and proactive during the COVID-19 public health crisis, by visiting www.hematology.org/COVID-19. If you have recommendations for topics to cover in this podcast series, please email us at thehematologist@hematology.org.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

COVID-19 Update 11: How COVID-19 Is Affecting Clinical Trainees, With Drs. Michaelis & Alice Ma

The Hematologist — Tue, 26 May 2020 09:59:27 -0400

In this installment, The Hematologist Editor-in-Chief Dr. Laura Michaelis has a conversation with Dr. Alice Ma of the University of North Carolina at Chapel Hill. They discuss challenges facing clinical trainees during the COVID-19 public health crisis. Find additional ASH resources available to help the hematology community be prepared and proactive during the COVID-19 public health crisis, by visiting www.hematology.org/COVID-19. If you have recommendations for topics to cover in this podcast series, please email us at thehematologist@hematology.org.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

COVID-19 Update 10: Anticoagulation in Patients With COVID-19, With Drs. Laura Michaelis & Agnes Lee

The Hematologist — Wed, 13 May 2020 11:37:32 -0400

In this installment, The Hematologist Editor-in-Chief Dr. Laura Michaelis has a conversation with Dr. Agnes Lee of The University of British Columbia. They discuss controversies surrounding anticoagulation in patients with COVID-19. Find additional ASH resources available to help the hematology community be prepared and proactive during the COVID-19 public health crisis, by visiting www.hematology.org/COVID-19. If you have recommendations for topics to cover in this podcast series, please email us at thehematologist@hematology.org.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

COVID-19 Update 9: ASH RC COVID-19 Registry, With Drs. Laura Michaelis, Lisa Hicks, and Bill Wood

The Hematologist — Fri, 08 May 2020 10:23:44 -0400

In this installment, The Hematologist Editor-in-Chief Dr. Laura Michaelis has a conversation with the co-chairs of the COVID-19 Registry For Hematologic Malignancy Task Force, Drs. Lisa Hicks and Bill Wood. They talk about the ASH Research Collaborative Data Hub’s recent launch of a COVID-19 Registry, which is currently capturing data on people who test positive for COVID-19 and have been or are currently being treated for hematologic malignancy. Later this month, the registry will include nonmalignant hematologic conditions. Access the registry by visiting www.ashresearchcollaborative.org/covid-19-registry. Find additional ASH resources available to help the hematology community be prepared and proactive during the COVID-19 public health crisis, by visiting www.hematology.org/COVID-19. If you have recommendations for topics to cover in this podcast series, please email us at thehematologist@hematology.org.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

COVID-19 Update 8: Managing the Blood Supply During COVID-19, With Drs. Michaelis & Margo Rollins

The Hematologist — Fri, 01 May 2020 12:53:03 -0400

In this installment, The Hematologist Editor-in-Chief Dr. Laura Michaelis has a conversation with Dr. Margo Rollins of Children’s Healthcare of Atlanta. They discuss the blood shortage during the COVID-19 public health crisis and what it means for individuals who have antibodies or unusual blood types. Find additional ASH resources available to help the hematology community be prepared and proactive during the COVID-19 public health crisis, by visiting www.hematology.org/COVID-19. If you have recommendations for topics to cover in this podcast series, please email us at thehematologist@hematology.org.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Gut Microbiome Diversity Influences Transplant Risk With Drs. Steven Lane & Jonathan Peled

The Hematologist — Fri, 01 May 2020 10:22:57 -0400

In this podcast, Contributing Editor Dr. Steven Lane has a conversation with Dr. Jonathan Peled. They discuss Dr. Lane's Diffusion article from the May/June 2020 issue of The Hematologist. The article titled, "Gut Microbiome Diversity Influences Transplant Risk," discusses a study that examined two cohorts from four separate transplant centers to determine how gut microbiome diversity influences transplant risk. You can find his Diffusion article online at www.hematology.org/Thehematologist/Diffusion/10374.aspx. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

COVID-19 Update 7: Managing Patients With SCD During COVID-19 Crisis, With Drs. Michaelis & Osunkwo

The Hematologist — Fri, 24 Apr 2020 15:59:49 -0400

In this installment, The Hematologist Editor-in-Chief Dr. Laura Michaelis has a conversation with Dr. Ifeyinwa (Ify) Osunkwo of The Levine Cancer Institute/Atrium Health. They discuss unique issues facing the sickle cell disease population during the COVID-19 public health crisis as well as some benefits of using telemedicine and telementoring. Find additional ASH resources available to help the hematology community be prepared and proactive during the COVID-19 public health crisis, by visiting www.hematology.org/COVID-19. If you have recommendations for topics to cover in this podcast series, please email us at thehematologist@hematology.org.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

COVID-19 Update 6: Hematologists on the Front Lines, With Drs. Michaelis, Phillips, & Abu-Zeinah

The Hematologist — Mon, 20 Apr 2020 16:43:34 -0400

In this installment, The Hematologist Editor-in-Chief Dr. Laura Michaelis has a conversation with Drs. Adrienne Phillips and Ghaith Abu-Zeinah of Weill Cornell Medical College. Drs. Phillips and Abu-Zeinah share their experience on the front lines of patient care and how they have handled working outside their field of expertise. Find additional ASH resources available to help the hematology community be prepared and proactive during the COVID-19 public health crisis, by visiting www.hematology.org/COVID-19. If you have recommendations for topics to cover in this podcast series, please email us at thehematologist@hematology.org.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

COVID-19 Update 5: Convalescent Serum Studies, With Drs. Laura Michaelis and Parameswaran Hari

The Hematologist — Thu, 16 Apr 2020 14:02:28 -0400

In this installment, The Hematologist Editor-in-Chief Dr. Laura Michaelis has a conversation with Dr. Parameswaran Hari of Medical College of Wisconsin. They discuss convalescent serum studies, including study design and outcomes, and what it’s like getting these studies up and running given current time constraints. Find additional ASH resources available to help the hematology community be prepared and proactive during the COVID-19 public health crisis, by visiting www.hematology.org/COVID-19. If you have recommendations for topics to cover in this podcast series, please email us at thehematologist@hematology.org.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

COVID-19 Update 4: Supporting Nurses, APPs, & Physicians With Drs. Laura Michaelis & Rachel Yehuda

The Hematologist — Mon, 13 Apr 2020 11:26:41 -0400

In this installment, The Hematologist Editor-in-Chief Dr. Laura Michaelis has a conversation with Dr. Rachel Yehuda of Mount Sinai and the James J. Peters VA Medical Center. They talk about measures hematologists can take to abrogate the psychological trauma to nurses, advanced practice providers, and physicians caring for patients with COVID-19. Find additional ASH resources available to help the hematology community be prepared and proactive during the COVID-19 public health crisis, by visiting www.hematology.org/COVID-19. If you have recommendations for topics to cover in this podcast series, please email us at thehematologist@hematology.org.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

COVID-19 Update 3: Social Media for Information Dissemination, Drs. Laura Michaelis & David Steensma

The Hematologist — Mon, 06 Apr 2020 14:54:06 -0400

In this installment, The Hematologist Editor-in-Chief Dr. Laura Michaelis has a conversation with ASH Clinical News Editor-in-Chief Dr. David Steensma. They talk about the strengths of using social media, particularly Twitter, as a source of information dissemination during a global public health crisis. Find additional ASH resources available to help the hematology community be prepared and proactive during the COVID-19 public health crisis, by visiting www.hematology.org/COVID-19. If you have recommendations for topics to cover in this podcast series, please email us at thehematologist@hematology.org.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

COVID-19 Update 2: Updates From New York City, With Drs. Stephanie Lee and Martin Tallman

The Hematologist — Wed, 01 Apr 2020 14:02:33 -0400

In this installment, ASH President Dr. Stephanie Lee has a conversation with ASH President-Elect Dr. Martin Tallman of Memorial Sloan Kettering Cancer Center in New York City. They talk about his work treating patients with leukemia and blood cancers during the COVID-19 outbreak, and how ASH can be a resource for hematologists throughout the United States and globally. Find additional ASH resources available to help the hematology community be prepared and proactive during the COVID-19 public health crisis, by visiting www.hematology.org/COVID-19.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

How ASH Supports the Hematology Community During COVID-19, With Drs. Stephanie Lee & Laura Michaelis

The Hematologist — Wed, 25 Mar 2020 10:36:03 -0400

In this installment, Editor-in-Chief Dr. Laura Michaelis has a conversation with ASH President Dr. Stephanie Lee. They talk about what it’s like for hematologists on the front lines of battling COVID-19 and how ASH leadership and members are coming together to leverage our resources and information-dissemination infrastructure. Find additional ASH resources available to help the hematology community be prepared and proactive during the COVID-19 public health crisis, by visiting www.hematology.org/COVID-19.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

How FLT3-ITDs & NPM1 Insertions Maneuver Into AML Using Lymphoid Enzyme TdT With Drs. Kim & Borrow

The Hematologist — Tue, 10 Mar 2020 12:26:44 -0400

In this podcast, Contributing Editor Dr. Annette Kim has a conversation with Dr. Julian Borrow. They discuss Dr. Kim's Diffusion article from the March/April 2020 issue of The Hematologist. The article titled, "How FLT3-ITDs and NPM1 Insertions Maneuver Into AML Using the Lymphoid Enzyme TdT to Initiate Replication Slippage," discusses the prominent role of TdT in the generation of FLT3-ITD and NPM1c mutations in acute myeloid leukemia (AML). You can find her (and co-author, Dr. John LaMacchia's) Diffusion article online at www.hematology.org/Thehematologist/Diffusion/10277.aspx. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

ASH-LLS Clinical Trial Support Center Collaboration With Drs. Gwen Nichols & Jennifer Holter

The Hematologist — Wed, 05 Feb 2020 12:00:20 -0500

In this installment, Dr. Gwen Nichols of The Leukemia & Lymphoma Society (LLS) has a conversation with Dr. Jennifer Holter-Chakrabarty of the ASH Taskforce on Immunotherapy. They talk about the collaboration between ASH and LLS to help ASH members and their patients navigate and find appropriate clinical trials, using LLS’s Clinical Trial Support Center. Learn more by visiting www.hematology.org/ClinicalTrialNavigation. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Year's Best in SCD: A Global Perspective on Pregnancy in 2019 With Drs. Osunkwo & Michaelis

The Hematologist — Tue, 21 Jan 2020 14:17:26 -0500

In this podcast, Editor-in-Chief Dr. Laura Michaelis has a conversation with Contributing Editor Dr. Ifeyinwa Osunkwo. They discuss Dr. Osunkwo's Year's Best article from the January/February 2020 issue of The Hematologist. The article titled, "The Year's Best in Sickle Cell Disease: A Global Perspective on Pregnancy in 2019," discusses efforts in 2019 to patch the gaps in our understanding of maternal and fetal management and outcomes of pregnancy in sickle cell disease. You can find her Year's Best article online at www.hematology.org/Thehematologist/Years-Best/10167.aspx. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

The Hematologist & ASH News Daily Editors on Contributing to ASH Pubs With Drs. Michaelis and Zia

The Hematologist — Mon, 02 Dec 2019 09:27:29 -0500

In this podcast, The Hematologist Editor-in-Chief, Dr. Laura Michaelis has a conversation with 2019 ASH News Daily Editor-in-Chief, Dr. Ayesha Zia. They discuss responsibilities of an Editor-in-Chief, how ASH News Daily and The Hematologist serve as resources for hematologists, especially ASH News Daily for annual meeting attendees as well as those who will miss the meeting this year in Orlando, and what interested listeners can do to get involved with these two ASH publications. Learn more by visiting www.hematology.org/thehematologist and ashnewsdaily.org. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Navigating the 2019 ASH Annual Meeting: PhDs, With Drs. Andrew Volk and Heather O'Leary

The Hematologist — Fri, 22 Nov 2019 09:47:12 -0500

In this podcast, Drs. Andrew Volk and Heather O'Leary help the PhD community navigate the upcoming 61st ASH Annual Meeting taking place December 7 to 10, in Orlando. They provide important information about events, sessions, and features that could benefit the PhD community. For more information about these resources and what to expect in Orlando, visit www.hematology.org/annual-meeting. “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Amino Acid Metabolism and the Leukemia Stem Cell With Drs. O'Dwyer, Liesveld, and Jones

The Hematologist — Fri, 01 Nov 2019 11:42:49 -0400

In this podcast, Contributing Editor Dr. Kristen O'Dwyer has a conversation with Dr. Jane Liesveld and Dr. Courtney Jones. They discuss Drs. O'Dwyer and Liesveld's Diffusion article from the November/December 2019 issue of The Hematologist. The article titled, "Outfoxing OXPHOS: Amino Acid Metabolism and the Leukemia Stem Cell," discusses how cysteine depletion targets leukemia stem cells through inhibition of electron transport complex II. You can find their Diffusion article online at www.hematology.org/Thehematologist/Diffusion/9976.aspx. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Navigating the 2019 ASH Annual Meeting: Hemostasis & Thrombosis, With Drs. Flaumenhaft & Di Paola

The Hematologist — Tue, 01 Oct 2019 14:00:28 -0400

In this podcast, Drs. Robert Flaumenhaft and Jorge Di Paola help the Hemostasis and Thrombosis (H&T) community navigate the upcoming 61st ASH Annual Meeting taking place December 7 to 10, in Orlando. They provide important information about events, sessions, and features that could benefit the H&T community. For more information about these resources and what to expect in Orlando, visit www.hematology.org/annual-meeting. “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Is the Future of the Benign Hematology Consult Electronic? With Drs. Stephan Moll and Ashok Pai

The Hematologist — Sun, 01 Sep 2019 09:00:06 -0400

In this podcast, Contributing Editor Dr. Stephan Moll has a conversation with Dr. Ashok Pai. They discuss Dr. Moll's Diffusion article from the September/October 2019 issue of The Hematologist. The article titled, "Is the Future of the Benign Hematology Consult Electronic?," discusses a virtual nonmalignant hematology consultation service, or e-consult, as a promising new approach that maximizes access to nonmalignant hematology expertise. You can find his Diffusion article online at www.hematology.org/Thehematologist/Diffusion/9802.aspx. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

How to Navigate the 2019 ASH Annual Meeting: A Guide for Trainees, With Drs. Nelson, May, and Cruz

The Hematologist — Thu, 29 Aug 2019 11:40:35 -0400

In this podcast, ASH Trainee Council members, Drs. Marquita Nelson and Jori May help trainees navigate the upcoming 61st ASH Annual Meeting taking place December 7 to 10, in Orlando (and ASH-a-Palooza on December 6). They provide important information about events, sessions, and features that could benefit the trainee community. Dr. Nicole Cruz joins them to provide some important tips to help trainees make the most out of their time at the 2019 ASH Annual Meeting. For more information about these resources and what to expect in Orlando, visit www.hematology.org/annual-meeting. “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Announcement: New ASH Annual Meeting Podcast Series Coming Soon!

The Hematologist — Thu, 08 Aug 2019 10:08:32 -0400

The Hematologist will be launching a new podcast series leading up to the 2019 ASH Annual Meeting. Members of working groups will provide invaluable information for attendees to help them make the most out of their time in Orlando for the 61st ASH Annual Meeting and Exposition in December. The series will feature three personalized podcasts directed at the trainee, PhDs, and hemostasis and thrombosis communities. Stay tuned! The first podcast will be released at the end of August. For more information, visit www.hematology.org/annual-meeting. “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Piecing Together the Bone Marrow Niche With Drs. Steven Lane and Anastasia Tikhonova

The Hematologist — Mon, 01 Jul 2019 13:05:20 -0400

In this podcast, Contributing Editor Dr. Steven Lane has a conversation with Dr. Anastasia Tikhonova. They discuss Dr. Lane’s Diffusion article from the July/August 2019 issue of The Hematologist. The article titled, “Piecing Together the Bone Marrow Niche,” looks at Dr. Tikhonova and colleagues’ use of single-cell and bulk mRNA sequencing to define the bone marrow microenvironment. You can find his Diffusion article online at www.hematology.org/Thehematologist/Diffusion/9639.aspx. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

NHLBI Resources and Grants for Hematologists With Drs. Donna DiMichele and Keith Hoots

The Hematologist — Wed, 19 Jun 2019 14:39:02 -0400

In this podcast, Dr. Donna DiMichele and Dr. Keith Hoots of the National Heart, Lung, and Blood Institute (NHLBI), talk about NHLBI and National Institutes of Health resources and grants available to hematologists. They provide important information about the new Career Pathway to Independence in Blood Science Award for Physician Scientists, stress the significance of working with program officers, and advise applicants on how to make the application process as smooth as possible. Find additional information online at www.nhlbi.nih.gov/ and learn about grants and resources by visiting www.grants.nih.gov/grants. 3:27 - "How do you access these resources?" 3:32 - Information specific to PhD, post doc, or physician scientists 5:15 - next steps, obtaining an independent career award (K series) 5:40 - grants and training website information; funding opportunity announcements and program officers 7:00 - importance of making contact with program officers 8:51 - Pilot: Career Pathway to Independence in Blood Science Award for Physician Scientists (K99 R00) 10:26 - challenges of going from K award to independent R01 award 12:53 - Clinician Scientist ESI Award 13:38 - examples of how program officers can be/have been helpful and instrumental; demystifying working with program officers 15:10 - importance of working with foundation partners and associations (for NHLBI) For information about the Career Pathway to Independence in Blood Science Award for Physician Scientists (K99 R00) visit the following pages: https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-20-002.html (K99/R00 Independent Clinical Trial Required) or https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-20-001.html (K99/R00 Independent Clinical Trial Not Allowed). For information about the Clinician Scientist ESI award, visit https://grants.nih.gov/grants/guide/rfa-files/rfa-hl-19-015.html. Dr. Keith Hoots is on Twitter — follow him and send in your questions @NHLBI_BLOODDir. Learn more about the NHLBI Division of Blood Diseases and Resources (DBDR) at https://www.nhlbi.nih.gov/about/divisions/division-blood-diseases-and-resources. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

A Step Forward in Treating AYA B-cell ALL With Drs. Kristen O'Dwyer and Wendy Stock

The Hematologist — Tue, 30 Apr 2019 13:30:39 -0400

In this podcast, Contributing Editor Dr. Kristen O'Dwyer has a conversation with Dr. Wendy Stock. They discuss Dr. O'Dwyer's Diffusion article from the May/June 2019 issue of The Hematologist. The article titled, "A Step Forward in the Treatment of Adolescent and Young Adult B-cell Acute Lymphoblastic Leukemia," covers the CALGB 10403 study, a trial that tests the efficacy and feasibility of a pediatric regimen for older adolescents and young adults with newly diagnosed B- or T-lineage Philadelphia chromosome-negative acute lymphoblastic leukemia. You can find her Diffusion article online at https://www.hematology.org/Thehematologist/Diffusion/9578.aspx. Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

ASH SCD Guidelines - SCD-Related Transplantation With Drs. John Tisdale and Hassan Murad

The Hematologist — Wed, 10 Apr 2019 13:47:45 -0400

In this podcast, Dr. Hassan Murad interviews Dr. John Tisdale about the clinical importance of ASH Guidelines on SCD, specifically the guideline opening April 10, 2019, for public comment, Sickle Cell Disease-Related Transplantation. To access and comment on these guidelines, visit www.hematology.org/guidelines-public-comment. The comment period will open April 10 and close May 13, 2019. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

ASH SCD Guidelines - SCD-Related Pain With Drs. Amanda Brandow and Eddy Lang

The Hematologist — Wed, 10 Apr 2019 13:47:35 -0400

In this podcast, Dr. Amanda Brandow and Dr. Eddy Lang discuss the clinical importance of ASH Guidelines on SCD, specifically the guideline opening April 10, 2019, for public comment, Sickle Cell Disease-Related Pain. To access and comment on these guidelines, visit www.hematology.org/guidelines-public-comment. The comment period will open April 10 and close May 13, 2019. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

What's New for the ASH-SAP, 7th Edition, With Drs. Adam Cuker and Aaron Gerds

The Hematologist — Mon, 01 Apr 2019 10:01:39 -0400

In this podcast, ASH-SAP Senior Executive Editor Dr. Adam Cuker and ASH-SAP Associate Editor Dr. Aaron Gerds talk about the upcoming seventh edition of the ASH Self-Assessment Program (ASH-SAP). They discuss new features, including new content and an updated multimedia program featuring both illustrated and 3D animation, which together cover the latest advancements in malignant and nonmalignant disorders, laboratory hematology, transfusion medicine, and other areas of hematology. Learn more by visiting www.ash-sap.org. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Keeping Your ESCHELONs Straight With Drs. Brad Kahl and Steven Horwitz

The Hematologist — Tue, 05 Mar 2019 09:13:45 -0500

In this podcast, Contributing Editor Dr. Brad Kahl has a conversation with Dr. Steven Horwitz. They discuss Dr. Kahl's Diffusion article from the March/April 2019 issue of The Hematologist. The article titled, "Keeping Your ESCHELONs Straight," covers the ESCHELON-2 study, a trial that used a "repeal and replace" strategy, eliminating vincristine from the experimental regimen and substituting in brentuximab vedotin to treat CD30+ T-cell lymphoma. You can find his Diffusion article online at www.hematology.org/Thehematologist/Diffusion/9387.aspx. Dr. Steven Horwitz conflicts of interest include: He has received grants and research support from ADCT Therapeutics, Aileron, Celgene, Forty-Seven, Infinity/Verastem, Kyowa-Hakka-Kirin, Millenium/Takeda, Seattle Genetics and Trillipum, and is a consultant for ADCT Therapeutics, Aileron, Corvus, Forty-Seven, Innate Pharma, Kyowa-Hakka, Kirin, Takeda, Miragen, Mundipharma, Portola, Seattle Genetics, Beigene, Affimed, and Verastem. Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

ASH Medical Educators Institute With Drs. Marc Kahn and Ariela Marshall

The Hematologist — Tue, 12 Feb 2019 16:49:35 -0500

In this podcast, Dr. Marc Kahn and Dr. Ariela Marshall talk about their experience with the ASH Medical Educators Institute, a "boot camp" in teaching techniques, medical education scholarship, and career development for hematologists and fellows who are new to or in the early phases of medical education careers. For more information about this program and to submit your application by the deadline of March 31, 2019, visit www.hematology.org/MEI. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Year's Best: Deciphering Dilemmas Posed by Detection of Mutant Myeloid Clones (Roberts & Michaelis)

The Hematologist — Tue, 01 Jan 2019 09:00:16 -0500

In this Year's Best podcast, Editor-in-Chief of The Hematologist Dr. Laura Michaelis has a conversation with Contributing Editor Professor Andrew Roberts. They discuss Dr. Robert's Year's Best article, which appears in the January/February 2019 issue of The Hematologist, titled "Deciphering the Dilemmas Posed by Detection of Mutant Myeloid Clones." They discuss advancements relating to clonal hematopoiesis of indeterminate potential or CHIP from 2018, and what they mean for healthy individuals with no history of blood disorders. You can find the Year's Best article online at www.hematology.org/Thehematologist/Years-Best/9299.aspx. Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

ASH VTE Guidelines - Treatment of Acute VTE With Drs. Thomas Ortel and Ignacio Neumann

The Hematologist — Fri, 30 Nov 2018 22:30:57 -0500

In this podcast, Dr. Thomas Ortel and Dr. Ignacio Neumann discuss the clinical importance of ASH Guidelines on VTE, specifically the guideline opening November 30, 2018, for public comment, Treatment of Acute VTE. To access and comment on these guidelines, visit www.hematology.org/guidelines-public-comment. The comment period will open November 30 and close January 18, 2019. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

What to Expect at the 60th ASH Annual Meeting With Drs. Hamadani, Sekeres, and Sola-Visner

The Hematologist — Wed, 21 Nov 2018 16:16:01 -0500

In this podcast, 2018 ASH News Daily Editor-in-Chief Dr. Mehdi Hamadani has a conversation with Education Program Co-chair Dr. Mikkael Sekeres and Scientific Program Co-chair Dr. Martha Sola-Visner about what to expect at the 60th ASH Annual Meeting and Exposition, taking place December 1-4, 2018, in San Diego, California. They talk about stimulating sessions to look forward to, new exciting features and features from previous years that are making their return such as Alexa-Ask ASH and Collaboration Rooms, as well as an array of networking events. Attendees will have the opportunity to connect with the top minds in the field of malignant and nonmalignant hematology as well as a global community of over 25,000 hematology professionals from every subspecialty. For more information about attending the ASH annual meeting, visit www.hematology.org/annual-meeting. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

ASH ITP Guidelines - Evaluation and Management of ITP With Drs. Cindy Neunert and Sara Vesely

The Hematologist — Tue, 13 Nov 2018 09:36:42 -0500

In this podcast, Dr. Cindy Neunert and Dr. Sara Vesely discuss the clinical importance of ASH Guidelines on ITP, specifically the guideline opening November 9, 2018, for public comment, Evaluation and Management of ITP. To access and comment on these guidelines, visit www.hematology.org/guidelines-public-comment. The comment period will open November 9 and close December 10, 2018. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Navigating the ASH Career Development Pathway With Drs. Alexis Thompson and Melody Smith

The Hematologist — Wed, 31 Oct 2018 16:52:49 -0400

In this podcast, ASH President Dr. Alexis Thompson has a conversation with Dr. Melody Smith about Dr. Smith's experience navigating the ASH career development and leadership pathways to help inspire aspiring hematologists and inform them of all the resources available through ASH. Learn more by visiting www.hematology.org/awards. **Apply for the ASH Minority Medical Student Award Program by January 15, 2019, by visiting http://www.hematology.org/Awards/Medical-Student/383.aspx. Apply for the ASH Minority Resident Hematology Award Program by January 15, 2019, by visiting http://www.hematology.org/Medical-Student/MRHAP/. Learn more about other programs and application deadlines via www.hematology.com/awards. Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Molecular Engineering Transforms the Outlook of Hemophilia A With Profs. Paul Moss & Johnny Mahlangu

The Hematologist — Wed, 24 Oct 2018 18:55:55 -0400

In this podcast, Contributing Editor Professor Paul Moss has a conversation with Professor Johnny Mahlangu. They discuss Dr. Moss's Diffusion article from the November/December 2018 issue of The Hematologist. The article titled, "Mimicry Not Replacement: Molecular Engineering Transforms the Outlook in Hemophilia A," covers the HAVEN3 study, which focuses on the activity of prophylactic emicizumab in patients with hemophilia who do not have inhibitors. You can find his Diffusion article online at www.hematology.org/Thehematologist/Diffusion/9049.aspx. Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

ASH SCD Guidelines - SCD-Related Cardiopulmonary & Kidney Disease With Drs. Liem, Lanzkron & Mustafa

The Hematologist — Tue, 25 Sep 2018 17:12:39 -0400

In this podcast, Dr. Robert Liem, Dr. Sophie Lanzkron, and Dr. Reem Mustafa discuss the clinical importance of ASH Guidelines on SCD, specifically the guideline opening September 24, 2018, for public comment, SCD-Related Cardiopulmonary and Kidney Disease. To access and comment on these guidelines, visit www.hematology.org/guidelines-public-comment. The comment period will open September 24 and close November 5, 2018. Additional ASH Guidelines on SCD will become available in 2019. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

ASH SCD Guidelines - SCD-Related Cerebrovascular Disease With Drs. Michael DeBaun & Hassan Murad

The Hematologist — Tue, 25 Sep 2018 17:12:25 -0400

In this podcast, Dr. Michael DeBaun and Dr. Hassan Murad discuss the clinical importance of ASH Guidelines on SCD, specifically the guideline opening September 24, 2018, for public comment, SCD-Related Cerebrovascular Disease. To access and comment on these guidelines, visit www.hematology.org/guidelines-public-comment. The comment period will open September 24 and close November 5, 2018. Additional ASH Guidelines on SCD will become available in 2019. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Circulating Tumor DNA in Lymphoma Monitoring With Drs. Annette Kim and Davide Rossi

The Hematologist — Tue, 18 Sep 2018 17:29:01 -0400

In this podcast, Contributing Editor Dr. Annette Kim has a conversation with Dr. Davide Rossi. They discuss Dr. Kim's Diffusion article from the September/October 2018 issue of The Hematologist. The article titled, "Circulating Tumor DNA in Lymphoma Monitoring: Fantasy, Fad, or Fact?," covers a study that showcases the utility of circulating tumor DNA monitoring in classic Hodgkin lymphoma. You can find her Diffusion article online at www.hematology.org/Thehematologist/Diffusion/8943.aspx. Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

ASH SCD Guidelines - SCD-Related Transfusion Support With Drs. Stella Chou & Jo Howard

The Hematologist — Mon, 20 Aug 2018 09:38:37 -0400

In this podcast, Dr. Stella Chou and Dr. Jo Howard discuss the clinical importance of ASH Guidelines on SCD, specifically the guideline opening August 20, 2018, for public comment, SCD-Related Transfusion Support. To access and comment on these guidelines, visit www.hematology.org/guidelines-public-comment. The comment period will open August 20 and close October 1, 2018. Additional ASH Guidelines on SCD will become available in the next two months. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

ASH-a-Palooza With Drs. Leidy Isenalumhe and Alex Boucher

The Hematologist — Fri, 03 Aug 2018 09:07:01 -0400

In this podcast, former Chair of the ASH Trainee Council Dr. Leidy Isenalumhe and current Chair of the ASH Trainee Council Dr. Alex Boucher have a conversation about the re-imagined Trainee Day, now known as ASH-a-Palooza, taking place at the 2018 ASH Annual Meeting. ASH-a-Palooza will offer a relaxed, open learning environment for trainees in a festival-like setting with multiple opportunities for micro learning. The event will take place Friday, November 30, 2018, right before the annual meeting starts on Saturday, December 1. For additional details including a preliminary schedule and location information, visit www.hematology.org/ashapalooza. Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

ASH VTE Guidelines - Prevention of VTE in Surgical Patients With Drs. David Anderson & Philipp Dahm

The Hematologist — Wed, 11 Jul 2018 14:26:00 -0400

In this podcast, Dr. David Anderson and Dr. Philipp Dahm discuss the clinical importance of new ASH Guidelines on VTE, specifically the guideline currently open for public comment, Prevention of VTE in Surgical Patients. To access and comment on these guidelines, visit www.hematology.org/guidelines-public-comment. The comment period closes July 25, 2018. Additional ASH Guidelines on VTE will become available for comment online throughout the next four to six months. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

New Means to Reactivate p53 in Leukemia With Drs. Omar Abdel-Wahab, Ulrich Steidl, and Amit Verma

The Hematologist — Mon, 02 Jul 2018 09:01:02 -0400

In this podcast, Contributing Editor Dr. Omar Abdel-Wahab has a conversation with Drs. Ulrich Steidl and Amit Verma. They discuss Dr. Abdel-Wahab's Diffusion article from the July/August 2018 issue of The Hematologist. The article titled, "New Means to Reactivate p53 in Leukemia: A Staple Peptide Inhibitor of MDMX and MDM2," discusses therapeutic activation of wild-type TP53 in leukemia and other forms of cancer. You can find the Diffusion article online at www.hematology.org/Thehematologist/Diffusion/8673.aspx. Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

ASH Congressional Fellowship With Drs. Alan Rosmarin, Joseph Alvarnas, and Catherine Zander

The Hematologist — Wed, 20 Jun 2018 10:39:56 -0400

In this podcast, Chair of the ASH Committee on Practice Dr. Joseph Alvarnas and Chair of the ASH Committee on Government Affairs Dr. Alan Rosmarin talk about the ASH Congressional Fellowship, a unique opportunity for a hematologist to work in a congressional office on Capitol Hill for an academic year, to help shape health care and hematology policy. We also hear from Dr. Catherine Zander, the first ever ASH Congressional Fellow, as she shares her personal experience with the fellowship. For more information, visit www.hematology.org/congressionalfellowship. Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

In Vivo and In-stantaneous Production of CAR T Cells With Drs. Caron Jacobson and Marcela Maus

The Hematologist — Wed, 23 May 2018 10:02:19 -0400

In this podcast, Contributing Editor Dr. Caron Jacobson and Dr. Marcela Maus both of Dana Farber Cancer Institute have a thought provoking conversation. They discuss Dr. Jacobson's Diffusion article from the May/June 2018 issue of The Hematologist. The article titled, "In Vivo and In-stantaneous Production of Chimeric Antigen Receptor T Cells: Overcoming Treatment Delays" talks about the in vivo and instantaneous production of chimeric antigen receptor T cells as a way to overcome potentially rate-limiting manufacturing times needed for current ex vivo technologies. You can find the Diffusion article online at www.hematology.org/Thehematologist/Diffusion/8464.aspx. Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Biosimilars With Drs. Joseph Alvarnas and Gary Lyman

The Hematologist — Fri, 27 Apr 2018 13:12:51 -0400

In this podcast, Chair of the ASH Committee on Practice Dr. Joseph Alvarnas has a conversation with Biosimilars Faculty Member Dr. Gary Lyman about the webinar series "Biosimilars: A New Era of Hematology/Oncology Management Considerations." They discuss the significance of these webinars for hematologists and their patients, as well as the importance of preparing clinicians with information that can provide context for the appropriate use of biosimilars. Learn more and listen to these webinars by visiting programs.ashacademy.org/biosimilars. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Drs. DeBaun & Field on What We Know/Don't Know About Chronic Pain in Adults With Sickle Cell Disease

The Hematologist — Fri, 30 Mar 2018 12:57:07 -0400

In this podcast, Contributing Editor Dr. Michael DeBaun of Vanderbilt University has a conversation with Dr. Joshua Field of BloodCenter of Wisconsin where they cover Dr. DeBaun's Diffusion article from the March/April 2018 issue of The Hematologist. The article titled "What We Know and Do Not Know About Chronic Pain in Adults With Sickle Cell Disease" discusses available information on recurrent chronic pain, the most common problem affecting 50 percent of adults with sickle cell disease (SCD). You can find the Diffusion article online at www.hematology.org/Thehematologist/Diffusion/8264.aspx. Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

ASH Global Initiatives With Drs. Theresa Coetzer and Eduardo Rego

The Hematologist — Mon, 26 Feb 2018 09:57:31 -0500

In this podcast, Chair of the International Members Committee Dr. Theresa Coetzer has a conversation with Vice-Chair of the International Members Committee Dr. Eduardo Rego about ASH global initiatives and the impact they have on international hematologists and their patients, as well as the integral role ASH members play in making these programs a reality. Visit www.hematology.org/global to learn more. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Year's Best: A Landmark Year for FDA-Approved Therapies for AML, With Drs. Abdel-Wahab and Michaelis

The Hematologist — Mon, 22 Jan 2018 09:53:49 -0500

In this Year's Best podcast, Editor-in-Chief of The Hematologist Dr. Laura Michaelis of Medical College of Wisconsin has a conversation with Contributing Editor Dr. Omar Abdel Wahab of Memorial Sloan Kettering. They discuss Dr. Abdel-Wahab's Year's Best article, which appears in the January/February 2018 issue of The Hematologist, titled "A Landmark Year for FDA-Approved Therapies for Acute Myeloid Leukemia." They have an exciting discussion about the U.S. Food and Drug Administration approval in 2017 of four new therapeutic options for treating acute myeloid leukemia patients. You can find the Year's Best article online at www.hematology.org/Thehematologist/Years-Best/8155.aspx. Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

ASH VTE Guidelines - Diagnosis of VTE With Drs. Wendy Lim and Reem Mustafa

The Hematologist — Wed, 20 Dec 2017 11:31:32 -0500

In this podcast, Dr. Wendy Lim and Dr. Reem Mustafa discuss the clinical importance of new ASH Guidelines on VTE, specifically one of the guidelines now open for public comment, Diagnosis of VTE. To access and comment on these guidelines, visit www.hematology.org/guidelines-public-comment. The comment period is open from December 5, 2017 to January 15, 2018. For more information, visit www.hematology.org/guidelines. Four additional ASH Guidelines on VTE will become available for comment online throughout the next four to six months. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

What to Expect at the 59th ASH Annual Meeting with Drs. Usmani, Sehn and Weyrich

The Hematologist — Fri, 01 Dec 2017 13:01:34 -0500

In this podcast, 2017 ASH News Daily Editor-in-Chief Dr. Saad Usmani has a conversation with Education Program Co-chair Dr. Laurie Sehn and Scientific Program Co-chair Dr. Andrew Weyrich about what to expect at the 59th ASH Annual Meeting and Exposition, taking place December 9-12, 2017, in Atlanta, Georgia. They talk about stimulating sessions to look forward to, new exciting features and features from previous years that are making their return such as the ASH White Board and Collaboration Rooms, as well as an array of networking events. Attendees will have the opportunity to connect with the top minds in the field of malignant and nonmalignant hematology as well as a global community of over 25,000 hematology professionals from every subspecialty. For more information about attending the ASH Annual Meeting, visit www.hematology.org/annual-meeting. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

ASH VTE Guidelines - Optimal Management of Anticoagulation Therapy With Drs. Witt & Crowther

The Hematologist — Thu, 30 Nov 2017 10:06:53 -0500

In this podcast, Dr. Dan Witt and Dr. Mark Crowther discuss the clinical importance of new ASH Guidelines on VTE, specifically the guideline opening for public comment, Optimal Management of Anticoagulation Therapy. To access and comment on these guidelines, visit www.hematology.org/guidelines-public-comment. The comment period is open from December 5, 2017 to January 15, 2018. For more information, visit www.hematology.org/guidelines. Five additional ASH Guidelines on VTE will become available for comment online throughout the next four to six months. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Use of Vitamin C in Treatment of Leukemia with Drs. Abdel-Wahab, Cimmino and Abdul-Hay

The Hematologist — Wed, 01 Nov 2017 11:11:27 -0400

In this podcast, Contributing Editor Dr. Omar Abdel-Wahab has a conversation with Dr. Luisa Cimmino and Dr. Maher Abdul-Hay of NYU School of Medicine. They discuss Dr. Abdel-Wahab's Diffusion article, which appears in the November/December 2017 issue of The Hematologist, titled "Vitamin C Treatment Restores TET2-Deficiency and Confers Sensitivity to PARP Inhibition." This thought-provoking conversation touches on the use of vitamin C to restore TET2-deficiency in the treatment of leukemia. You can find the Diffusion article online at www.hematology.org/Thehematologist/Diffusion/. Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Dr. Jason Gotlib Welcomes Dr. Laura Michaelis As the New Editor-in-Chief of The Hematologist

The Hematologist — Tue, 03 Oct 2017 07:38:18 -0400

In this podcast, Outgoing Editor-in-Chief of The Hematologist Dr. Jason Gotlib gives a warm welcome to Editor-in-Chief Designee Dr. Laura Michaelis. Dr. Michaelis' term begins in 2018. They discuss her vision for the publication including The Hematologist's digital presence, multimedia efforts, new columns, and untapped topics that require attention. Access The Hematologist online via www.hematology.org/thehematologist. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

ASH VTE Guidelines - Context of Pregnancy & HIT with Drs. Adam Cuker & Shannon Bates

The Hematologist — Fri, 22 Sep 2017 16:19:28 -0400

In this podcast, Dr. Adam Cuker and Dr. Shannon Bates discuss the clinical importance of new ASH Guidelines on VTE. The two guidelines currently open for public comment are VTE in the Context of Pregnancy and Heparin-Induced Thrombocytopenia. The deadline to comment on these is October 2. To access and comment on these guidelines, visit www.hematology.org/guidelines-public-comment. For more information, visit www.hematology.org/guidelines. Six additional ASH Guidelines on VTE will become available for comment online over the next four to six months. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Farming Hematopoietic Stem Cells with Drs. Jonathan Hoggatt & George Daley

The Hematologist — Fri, 01 Sep 2017 13:33:25 -0400

In his Diffusion article from the September/October 2017 issue of The Hematologist, Dr. Jonathan Hoggatt discusses efforts to grow hematopoietic stem cells to care for patients with diseases that can be treated with bone marrow transplantation. He covers a Nature article co-authored by Dr. George Daley, Dean of Harvard Medical School. In this podcast, Dean Daley joins Dr. Hoggatt for a thought provoking conversation about these efforts. You can find the Diffusion article online at www.hematology.org/Thehematologist/Diffusion/7583.aspx. **COI: Megakaryon has funded Dr. George Daley's lab/research. Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

ASH Guidelines on VTE for Public Comment: Pt. 1, Drs. Cuker/Schünemann; Pt. 2, Drs. Cushman/Monagle

The Hematologist — Wed, 09 Aug 2017 16:22:56 -0400

Part 1 (Dr. Cucker and Dr. Schünemann): Starts at 2:50 min. Part 2 (Dr. Cushman and Dr. Monagle): Starts at 26:00 min. In this podcast, Drs. Adam Cuker, Holger Schünemann, Mary Cushman and Paul Monagle talk about new ASH Guidelines on VTE, an ASH project started in 2015 to develop 10 evidence-based clinical practice guidelines on the diagnosis and treatment of venous thromboembolism (VTE), in collaboration with the McMaster University GRADE center. Two of these 10 guidelines are now available for public comment, and these members of the panels urge you to provide your input by the deadline of August 25, 2017. Part 1 of the podcast features a conversation between Dr. Cuker and Dr. Schünemann, and Part 2 features Dr. Cushman conversing with Dr. Monagle. Visit www.hematology.org/guidelines-public-comment to comment. For more information about ASH Clinical Practice Guidelines, visit www.hematology.org/guidelines. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

EINSTEIN CHOICE with Drs. Lori-Ann Linkins & Jeffrey Weitz

The Hematologist — Mon, 24 Jul 2017 09:47:46 -0400

In her Diffusion article from the July/August 2017 issue of The Hematologist, Dr. Lori-Ann Linkins takes a look at the EINSTEIN CHOICE Study and compares reducing the intensity of anticoagulant therapy or switching to aspirin as options for patients who wish to continue being protected from the risk of VTE. She covers a New England Journal of Medicine article co-authored by Dr. Jeffrey Weitz. In this podcast, Dr. Weitz joins Dr. Linkins for a discussion of the study's design, rationale and important findings. You can find the Diffusion article online at www.hematology.org/Thehematologist/Diffusion/7448.aspx. Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

ASH Advocacy and Policy Update with Drs. Alan Rosmarin and Joseph Alvarnas

The Hematologist — Wed, 28 Jun 2017 17:06:30 -0400

In this podcast, Chair of the ASH Committee on Practice Dr. Joseph Alvarnas and Chair of the ASH Committee on Government Affairs Dr. Alan Rosmarin, update ASH members on key policy topics affecting hematologists. They discuss the current political climate and its effects on issues impacting the field of hematology, including research funding, drug access and pricing issues, and efforts to repeal the Affordable Care Act. Drs. Rosmarin and Alvarnas provide information about ASH programs and resources hematologists, whether clinicians or researchers, can use to advocate for issues of importance to them and their patients. To learn about ASH's advocacy efforts and how you can get involved, visit www.hematology.org/advocacy. For more information about the ASH Congressional Fellowship Program and the ASH Advocacy Leadership Institute, visit the ASH website. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Precision Medicine at Work: A Conversation Between Drs. Sioban Keel and Benjamin Ebert

The Hematologist — Wed, 24 May 2017 09:16:28 -0400

In her Diffusion article from the May/June 2017 issue of The Hematologist, Dr. Sioban Keel looks at genetic profiling to guide stem-cell transplantation in myelodysplastic syndromes. She covers a New England Journal of Medicine article co-authored by Dr. Benjamin Ebert. In this podcast, Dr. Ebert joins Dr. Keel for a thought-provoking conversation. You can find the article online at www.hematology.org/Thehematologist/Diffusion/7259.aspx. Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

An Overview of the ASH Honorific Awards with Drs. Mohandas Narla and Linda Burns

The Hematologist — Wed, 26 Apr 2017 12:33:09 -0400

In this podcast, ASH Awards Committee members, Drs. Linda Burns and Mohandas Narla discuss ASH's most prestigious awards, the Honorifics. They provide a thorough overview of the seven awards, the nomination process, as well as the importance of nominating your colleagues to be honored for their achievements. These awards recognize hematologists for accomplishments that serve as building blocks for new medical advancements in hematology. To learn more about the ASH Honorific Awards, visit www.hematology.org/awards/honorific. Remember to submit your nominations by July 15, 2017.

Beat AML Trial Update With Dr. John Byrd, Dr. Elizabeth Raetz and Dr. Eytan Stein

The Hematologist — Mon, 20 Mar 2017 09:12:07 -0400

In her Clinical Trials Corner article from the March/April 2017 issue of The Hematologist, Dr. Elizabeth Raetz along with Dr. Tibor Kovacsovics take a look at the Beat AML Trial. In this podcast, and through ASH's partnership with the Leukemia and Lymphoma Society, AML experts Dr. John Byrd and Dr. Eytan Stein join Dr. Raetz in a conversation about the trial's design, rationale, and results, as well as its significance in developing a precision medicine approach for the treatment of acute myeloid leukemia. You can find the article online at www.hematology.org/Thehematologist/Clinical-Trials/7134.aspx. Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

The Year's Best in Sickle Cell Disease with Dr. Alexis Thompson and Dr. Jason Gotlib

The Hematologist — Tue, 24 Jan 2017 11:25:23 -0500

The first podcast of 2017 for The Hematologist: ASH News and Reports features Dr. Jason Gotlib (Stanford University School of Medicine) and Dr. Alexis Thompson (Ann and Robert H. Lurie Children's Hospital) having a conversation about the highlights of 2016 in sickle cell disease (SCD). They cover studies in SCD and ASH Sickle Cell Disease initiatives in order to demonstrate why it is such an exciting time for the study of this disease. You can read the Year's Best article authored by Dr. Michael DeBaun by visiting www.hematology.org/Thehematologist/Years-Best/6994.aspx. For more information about ASH SCD Initiatives, visit www.hematology.org/Advocacy/4329.aspx. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 crativecommons.org/licenses/by/3.0/

Drs. Aaron Gerds, Laurie Sehn and Michael Linenberger on Attending the 58th ASH Annual Meeting

The Hematologist — Mon, 28 Nov 2016 09:48:48 -0500

In this special podcast, Dr. Aaron Gerds (Cleveland Clinic) has a conversation with Dr. Laurie Sehn (University of British Columbia/BC Cancer Agency) about exciting events that will be taking place at this year's ASH annual meeting, which will take place December 3 to 6 in San Diego, California. The meeting will feature an array of education and scientific sessions, and oral and poster presentations detailing the latest clinical advances. There is also an expanded Education Program and a growing selection of special-interest sessions and networking events. Attendees will also have the opportunity to connect with the top minds in the field of malignant and nonmalignant hematology, as well as a global community of more than 20,000 hematology professionals from every subspecialty. The podcast also features important information provided by Dr. Michael Linenberger (University of Washington, Seattle Cancer Care Alliance, Fred Hutch) about obtaining CME credit for participating in the annual meeting. For more information about the 58th ASH Annual Meeting, visit www.hematology.org/annual-meeting. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Sickle Cell Trait Doesn’t Increase Mortality in Context of Universal Precautions Applied by US Army

The Hematologist — Mon, 14 Nov 2016 11:44:06 -0500

In his Diffusion article from the November/December issue of The Hematologist, Dr. Michael DeBaun (Vanderbilt University) discusses the need for further research in efforts to update and implement universal procedures to prevent unnecessary death and acute illness for college and high school athletes with SCD. He covered the article by Dr. Lianne Kurina (Stanford University) and colleagues titled “Sickle cell trait, rhabdomyolysis, and mortality among U.S. Army soldiers.” Dr. Kurina provides her insight on the issue based on her research program, which focuses on the physical and mental health of active-duty U.S. Army soldiers. You can find Dr. DeBaun’s Diffusion article online at www.hematology.org/Thehematologist/Diffusion/6722.aspx. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 crativecommons.org/licenses/by/3.0/

Celebrate 30 Years of ASH Scholar Awards with Drs. Gary Gilliland, Ross Levine and Omar Abdel-Wahab

The Hematologist — Mon, 31 Oct 2016 11:39:23 -0400

In this special podcast, Dr. Gary Gilliland from Fred Hutch and Drs. Ross Levine and Omar Abdel-Wahab from Memorial Sloan Kettering, talk about the significance of the ASH Scholar Award in their careers. This podcast, which follows the theme of “Three Generations of Scholar Award Recipients,” celebrates 30 years of the ASH Scholar Awards designed to support hematologists who have chosen a career in research by providing partial salary or other support during the critical period required for completion of training and achievement of status as an independent investigator. Dr. Gilliland was a Scholar Award recipient in 1991, Dr. Levine received his award in 2006, and Dr. Abdel-Wahab won twice – in 2011 as a fellow and in 2014 as basic/translational junior faculty. Learn more about ASH Scholar Awards by visiting www.hematology.org/awards. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

A Conversation about Theranos with Drs. Jason Gotlib, Rama Gullapalli, and Tracy George

The Hematologist — Fri, 09 Sep 2016 10:11:54 -0400

In our ninth podcast for The Hematologist, Dr. Tracy George (University of New Mexico School of Medicine) and Dr. Rama Gullapalli (University of New Mexico School of Medicine) have a conversation with Dr. Jason Gotlib (Stanford University School of Medicine) about lessons for clinicians and pathologists, learned from the Theranos controversy. The podcast covers the Op-Ed written by Drs. George and Gullapalli for the September/October 2016 issue of The Hematologist. Read the full article online at www.hematology.org/Thehematologist/Op-Ed/6540.aspx. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Dr. Ken Anderson and Dr. Martin Tallman on Attending the 2016 Meeting on Hematologic Malignancies

The Hematologist — Mon, 15 Aug 2016 15:49:49 -0400

In this special podcast, Dr. Ken Anderson and Dr. Martin Tallman, program co-chairs for the Meeting on Hematologic Malignancies, talk about the exciting events that will be taking place at this year’s meeting, which will take place September 16 to 17 at the Fairmont Chicago in Millennium Park, Chicago, Illinois. Attendees will have the opportunity to hear world-class experts in hematologic malignancies discuss the latest developments in clinical care, and learn about their own treatment approaches based on available data. The content will be structured as “How I Treat” sessions on core malignancies, including leukemia, lymphoma, myelodysplastic syndromes, myeloma, and myeloproliferative neoplasms. Among the dynamic areas the two Chairs discuss in this podcast, targeted and immune therapies are some of the most highly anticipated this year in Chicago. Also taking center-stage are several new areas of interest including immune therapies in leukemias, unique toxicities such as cytokine release syndrome and in curative disease types, and numerous others. As Drs. Anderson and Tallman spotlight, all of these discussions will take place in the context of actual clinical cases. For more information about the meeting, visit www.hematology.org/malignancies, and to register go to www.hematology.org/malignancies/registration.aspx. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Heparin-Induced Thrombocytopenia: A Preventable Nosocomial Disease

The Hematologist — Wed, 20 Jul 2016 15:33:45 -0400

In his Diffusion article from the July/August issue of The Hematologist, Dr. Adam Cuker (University of Pennsylvania) covers options to reduce the incidence of heparin-induced thrombocytopenia (HIT), treating it as a preventable nosocomial disease rather than an unavoidable iatrogenic disorder. He looks at the study “Reducing the hospital burden of heparin-induced thrombocytopenia: impact of an avoid-heparin program,” which was led by Dr. William Geerts (Sunnybrook Health Sciences Center) who joins Dr. Cuker in this stimulating conversation. You can find Dr. Cuker’s Diffusion article online at www.hematology.org/Thehematologist/Diffusion/5646.aspx. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

BCL-2 Is an Effective Target in Chronic Lymphocytic Leukemia

The Hematologist — Tue, 03 May 2016 15:26:11 -0400

In her Diffusion article from the May/June issue of The Hematologist, Dr. Ann LaCasce (Dana-Farber Cancer Institute) discusses the use of the recently FDA-approved drug venetoclax for the treatment of patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Dr. Andrew Roberts (Walter + Eliza Hall Institute of Medical Research) shares his thoughts about the drug and his experience with the first phase 1 dose-escalation study of daily oral venetoclax in patients with relapsed or refractory CLL/SLL in this thought-provoking conversation. You can find Dr. LaCasce’s Diffusion article online at www.hematology.org/Thehematologist/Diffusion/5479.aspx. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

A Conversation about the TWiTCH Trial with Dr. Russell Ware and Dr. Michael DeBaun

The Hematologist — Fri, 12 Feb 2016 11:13:24 -0500

In his Diffusion article from the March/April issue of The Hematologist, Dr. Michael DeBaun (Vanderbilt University School of Medicine) takes a look at the TWiTCH Trial, a multicenter, open-label, phase III, non-inferiority trial. Dr. Russell Ware (University of Cincinnati and Cincinnati Children's Hospital), the national Principal Investigator for this NIH-funded trial conducted under the sponsorship of an FDA IND, joins Dr. DeBaun in this conversation. You can find the diffusion online at www.hematology.org/Thehematologist/Diffusion/4943.aspx. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Interview with Dr. Jeffery Klco and Dr. Timothy Ley: Day-30 Mutation Analysis after AML Induction

The Hematologist — Tue, 10 Nov 2015 12:02:36 -0500

In her Diffusion article from the November/December issue of The Hematologist, Dr. Pamela Becker (Institute for Stem Cell and Regenerative Medicine and Center for Cancer Innovation, University of Washington, Seattle, WA) talks about the many mutations identified in acute myeloid leukemia (AML) and the efforts of investigators to find a practical application of this information in modifying treatment. Dr. Jeffry Klco (St. Jude Children’s Research Hospital, Memphis, TN) and Dr. Timothy Ley (McDonnell Genome Institute and Siteman Cancer Center, Washington University, St. Louis, MO), co-authors of the JAMA article join Dr. Becker in this discussion. You can find the diffusion online at www.hematology.org/Thehematologist/Diffusion/4487.aspx. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

Perioperative Bridging is Falling Down

The Hematologist — Tue, 25 Aug 2015 10:03:57 -0400

In his Diffusion article from the September/October issue of The Hematologist, Dr. Adam Cuker (Penn-CHOP Blood Center for Patient Care and Discovery, University of Pennsylvania, Philadelphia, PA) discusses the BRIDGE study, which was led by Dr. Thomas Ortel (Duke University Medical Center, Durham, NC). Dr. Cuker concludes that, while more data are needed, there may be high-risk patients or procedures for which bridging is appropriate, which were not originally covered in the study. In this podcast, Drs. Cuker and Ortel thoroughly discuss the design, outcomes, and limitations of the BRIDGE study and explore how its results may inform clinical practice and treatment of atrial fibrillation and other disorders. Read the article here: www.hematology.org/Thehematologist/Diffusion/4310.aspx Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

The Unfiltered Truth: Anticoagulation Alone is Highly Effective, even in Patients with High-risk PE

The Hematologist — Mon, 13 Jul 2015 12:22:17 -0400

In his recent Diffusion article from the July/August issue of The Hematologist, Dr. David Garcia (University of Washington School of Medicine, University of Washington Medical Center, Seattle, WA) discusses the PREPIC2 study. The PREPIC2 results, published in JAMA, highlight the benefits of well-managed anticoagulation in patients with high-risk pulmonary embolism. In this podcast, Dr. Garcia sheds additional light on the study as well as its ramifications throughout the field. The Hematologist Editor-in-Chief, Dr. Jason Gotlib (Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA) leads the discussion. Read the article here: http://www.hematology.org/Thehematologist/Diffusion/4130.aspx Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 http://creativecommons.org/licenses/by/3.0/

Navigating Future Challenges in Lymphoma

The Hematologist — Wed, 06 May 2015 09:21:16 -0400

The strategic roadmap developed at the original ASH Meeting on Lymphoma Biology held in August 2014 was recently published in Blood. To continue this important conversation, Dr. Ann LaCasce (Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA) and Dr. David Weinstock (Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA) have contributed a companion article, just published in the May/June issue of The Hematologist. This podcast features additional insight from the authors, with The Hematologist Editor-in-Chief Dr. Jason Gotlib (Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA) moderating the discussion. Read the article here: http://www.hematology.org/Thehematologist/Features/4003.aspx Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 http://creativecommons.org/licenses/by/3.0/